Adult drug category

Adult First line drugs:

		Acetic acid 2% spray	(12.1 Ear)
		Acetylcisteine (Acepiro) 600mg effervescent tablets	(3.3 Conditions affecting sputum viscosity)
		Aciclovir (oral)	(5.6 Viral infection)
		Aciclovir 5% cream	(13.2 Infections of the skin)
		Actrapid	(6.3 Diabetes mellitus and hypoglycaemia)
		Adapalene / Benzoyl peroxide gel (Epiduo)	(13.7 Rosacea and acne)
		Adapalene cream/gel 0.1% (Differin)	(13.7 Rosacea and acne)
		Admelog	(6.3 Diabetes mellitus and hypoglycaemia)
		Adrenaline (epinephrine) 1 in 10,000 (100micrograms/mL)	(2.7 Myocardial ischaemia)
		Adrenaline (epinephrine) 1 in 10,000 (100micrograms/mL)	(3.2 Allergic conditions)
		Adrenaline (epinephrine) 1 in 1000 (1mg/mL)	(3.2 Allergic conditions)
		Adsorbed Diphtheria (low dose), Tetanus and Inactivated Poliomyelitis vaccine	(14.4 Vaccination)
		Alendronic acid	(6.4 Disorders of bone metabolism)
		Alfacalcidol capsules/drops	(9.6 Vitamin deficiencies)
		Allopurinol	(10.2 Hyperuricaemia and gout)
		Alpha tocopheryl acetate suspension	(9.6 Vitamin deficiencies)
		Altraplen Energy	(9.5 Nutrition)
		Aluminium chloride hexahydrate 20% (Driclor)	(13.4 Perspiration)
		Amiloride	(2.8 Oedema)
		Amitriptyline tablets/liquid	(16.1 Pain due to cancer in adults- Palliative Care)
		Amitriptyline	(16.5 Mouthcare- Palliative Care)
		Amitriptyline	(4.5 Pain)
		Amlodipine	(2.4 Blood pressure conditions)
		Amoxicillin (oral)	(5.2 Bacterial infection)
		Anusol cream & suppositories	(1.9 Rectal and anal disorders)
		Anusol HC ointment & suppositories	(1.9 Rectal and anal disorders)
		Apidra	(6.3 Diabetes mellitus and hypoglycaemia)
		Apixaban	(2.3 Blood clots)
		Arachis oil enema	(1.2 Constipation and bowel cleansing)
		Artificial saliva spray (Oralieve)	(12.3 Oropharynx)
		Ascorbic acid (oral & parenteral)	(9.6 Vitamin deficiencies)
		Aspirin (off label)	(2.3 Blood clots)
		Aspirin (off label)	(8.2 Malignant disease)
		Aspirin	(2.3 Blood clots)
		Atenolol	(2.4 Blood pressure conditions)
		Atorvastatin	(2.6 Hyperlipidaemia)
		Atropine 1% eye drops	(11.5 Mydriatics and cycloplegics)
		Atropine	(15.1 General Anaesthesia)
		Aymes ActaSolve Protein Compact	(9.5 Nutrition)
		Aymes ActaSolve Delight	(9.5 Nutrition)
		Aymes Actasolve Savoury	(9.5 Nutrition)
		Aymes Actasolve Smoothie	(9.5 Nutrition)
		Aymes Shake Compact	(9.5 Nutrition)
		Aymes Shake Fibre (5g)	(9.5 Nutrition)
		Aymes Shake	(9.5 Nutrition)
		Azelaic acid cream 20% (Skinoren)	(13.7 Rosacea and acne)
		Azelastine / Fluticasone nasal spray (Dymista)	(12.2 Nose)
		Azelastine nasal spray (Rhinolast)	(12.2 Nose)
		Baclofen	(10.3 Neuromuscular disorders)
		Balneum Intensiv cream	(13.1 Dry and scaling skin disorders)
		Balneum Plus cream	(13.1 Dry and scaling skin disorders)
		BCG vaccine	(14.4 Vaccination)
		BD Levemir	(6.3 Diabetes mellitus and hypoglycaemia)
		Beclometasone (inhaled)	(3.1 Airways disease, obstructive)
		Beclometasone / Formoterol (Fostair NEXThaler)	(3.1 Airways disease, obstructive)
		Beclometasone / Formoterol (Fostair pMDI)	(3.1 Airways disease, obstructive)
		Beclometasone / Formoterol (Luforbec pMDI)	(3.1 Airways disease, obstructive)
		Beclometasone / Formoterol / Glycopyrronium (Trimbow Nexthaler DPI 88/5/9)	(3.1 Airways disease, obstructive)
		Beclometasone / Formoterol / Glycopyrronium (Trimbow pMDI 87/5/9)	(3.1 Airways disease, obstructive)
		Beclometasone nasal spray	(12.2 Nose)
		Benzalkonium chloride 0.5% shampoo (Dermax)	(13.8 Scalp and hair conditions)
		Benzoyl peroxide / Azelaic acid	(13.7 Rosacea and acne)
		Benzoyl peroxide 5% / Clindamycin 1% gel (Duac Once Daily)	(13.7 Rosacea and acne)
		Benzoyl peroxide 5% gel/cream	(13.7 Rosacea and acne)
		Benzydamine 0.15% oral rinse/spray (Difflam)	(12.3 Oropharynx)
		Betahistine	(4.4 Nausea and labyrinth disorders)
		Betamethasone (parenteral)	(6.2 Corticosteroid responsive conditions)
		Betamethasone 0.025% cream/ointment (Betnovate RD)	(13.3 Inflammatory skin conditions)
		Betamethasone 0.05% / Salicylic acid 3% ointment (Diprosalic)	(13.3 Inflammatory skin conditions)
		Betamethasone 0.1% / Clioquinol 3% cream/ointment	(13.3 Inflammatory skin conditions)
		Betamethasone 0.1% and Neomycin 0.5% (Betnesol-N)	(12.1 Ear)
		Betamethasone 0.1% cream/ointment/lotion (Betnovate)	(13.3 Inflammatory skin conditions)
		Betamethasone 0.1% drops	(12.1 Ear)
		Betamethasone 0.1% drops	(12.2 Nose)
		Betamethasone soluble tablets	(12.3 Oropharynx)
		Betamethasone tablets	(16.5 Mouthcare- Palliative Care)
		Bijuve	(6.8 Sex hormone responsive conditions)
		Bimizza	(7.3 Contraception)
		Bisacodyl	(16.2 Gastrointestinal symptoms- Palliative Care)
		Bisoprolol	(2.4 Blood pressure conditions)
		Brevinor	(7.3 Contraception)
		Brimonidine 0.2% eye drops	(11.6 Treatment of glaucoma)
		Brinzolamide 10mg/mL eye drops	(11.6 Treatment of glaucoma)
		Budesonide / Formoterol (DuoResp Spiromax)	(3.1 Airways disease, obstructive)
		Budesonide / Formoterol (Fobumix Easyhaler)	(3.1 Airways disease, obstructive)
		Budesonide / Formoterol (Symbicort)	(3.1 Airways disease, obstructive)
		Budesonide foam enema	(1.1 Chronic bowel disorders)
		Buprenorphine sublingual	(4.8 Substance dependence)
		Calcichew chewable tablets	(9.2 Fluid and electrolyte imbalances)
		Calcipotriol / Betamethasone 0.05% foam (Enstilar)	(13.3 Inflammatory skin conditions)
		Calcipotriol / Betamethasone 0.05% cream	(13.3 Inflammatory skin conditions)
		Calcipotriol / Betamethasone 0.05% gel & ointment (Dovobet)	(13.3 Inflammatory skin conditions)
		Calcipotriol ointment	(13.3 Inflammatory skin conditions)
		Calcitriol capsules	(9.6 Vitamin deficiencies)
		Calcium acetate (Renacet)	(9.2 Fluid and electrolyte imbalances)
		Calcium gluconate 10% 2.2mmols per 10mL (parenteral)	(9.2 Fluid and electrolyte imbalances)
		Calvive 1000	(9.2 Fluid and electrolyte imbalances)
		Canagliflozin	(6.3 Diabetes mellitus and hypoglycaemia)
		Candesartan	(2.4 Blood pressure conditions)
		Capsaicin cream	(4.5 Pain)
		Carbimazole	(6.9 Thyroid disorders)
		Carbocisteine	(3.3 Conditions affecting sputum viscosity)
		Cetirizine	(3.2 Allergic conditions)
		Chloramphenicol 0.5% eye drops	(11.3 Anti–infective eye preparations)
		Chloramphenicol 1% eye ointment	(11.3 Anti–infective eye preparations)
		Chlordiazepoxide	(4.8 Substance dependence)
		Chlorhexidine 0.1% / Neomycin 0.5% cream (Naseptin)	(12.2 Nose)
		Chlorhexidine 0.2% mouthwash	(12.3 Oropharynx)
		Chlorhexidine 1% dental gel	(12.3 Oropharynx)
		Chlorhexidine gluconate 4%	(13.9 Skin cleansers, antiseptics and desloughing agents)
		Chlorhexidine gluconate mouthwash	(16.5 Mouthcare- Palliative Care)
		Chlorphenamine (parenteral)	(3.2 Allergic conditions)
		Chlorphenamine	(3.2 Allergic conditions)
		Cholera	(14.4 Vaccination)
		Choline salicylate gel (Bonjela)	(12.3 Oropharynx)
		Cinnarizine	(4.4 Nausea and labyrinth disorders)
		Ciprofloxacin (oral)	(5.2 Bacterial infection)
		Citalopram	(16.4 Anxiety, depression and confusion- Palliative Care)
		Citalopram	(4.2 Mental health disorders)
		Citramag	(1.2 Constipation and bowel cleansing)
		Clarithromycin (oral)	(5.2 Bacterial infection)
		Clindamycin cream	(7.6 Vaginal and vulval conditions)
		Clindamycin solution/lotion (Dalacin T)	(13.2 Infections of the skin)
		Clobetasol propionate 0.05% / Neomycin sulphate 0.5% / Nystatin 100,000 units/g cream/ointment	(13.3 Inflammatory skin conditions)
		Clobetasol propionate 0.05% cream/ointment (Dermovate)	(13.3 Inflammatory skin conditions)
		Clobetasone butyrate 0.05% cream/ointment (Eumovate)	(13.3 Inflammatory skin conditions)
		Clopidogrel	(2.3 Blood clots)
		Clotrimazole 1% cream/solution	(13.2 Infections of the skin)
		Clotrimazole 1% cream	(7.6 Vaginal and vulval conditions)
		Clotrimazole pessary 500mg	(7.6 Vaginal and vulval conditions)
		Co-beneldopa (Madopar)	(4.3 Movement disorders)
		Co-careldopa (Sinemet)	(4.3 Movement disorders)
		Co-cyprindiol (Dianette)	(13.7 Rosacea and acne)
		Co-danthramer	(16.2 Gastrointestinal symptoms- Palliative Care)
		Co-danthrusate	(16.2 Gastrointestinal symptoms- Palliative Care)
		Co-trimoxazole (oral)	(5.3 Fungal infection)
		Coal tar and Salicylic acid ointment	(13.3 Inflammatory skin conditions)
		Codeine linctus	(16.3 Respiratory symptoms- Palliative Care)
		Codeine phosphate	(1.3 Diarrhoea)
		Codeine	(16.1 Pain due to cancer in adults- Palliative Care)
		Codeine	(4.5 Pain)
		Colchicine	(10.2 Hyperuricaemia and gout)
		Colecalciferol (oral)	(9.6 Vitamin deficiencies)
		Colecalciferol / Calcium (oral)	(9.6 Vitamin deficiencies)
		Colestyramine	(1.7 Liver disorders and related conditions)
		COVID vaccine	(14.4 Vaccination)
		Creon Capsules	(1.10 Reduced exocrine secretions)
		Creon Micro (granules)	(1.10 Reduced exocrine secretions)
		Crotamiton (Eurax)	(13.6 Pruritis)
		Cyclizine tablets / subcutaneous injection	(16.2 Gastrointestinal symptoms- Palliative Care)
		Cyclizine	(16.6 End of life symptom control- Palliative Care)
		Cyclizine	(4.4 Nausea and labyrinth disorders)
		Cyclopentolate 0.5 % or 1% eye drops	(11.5 Mydriatics and cycloplegics)
		Cytisinicline (cytisine)	(4.8 Substance dependence)
		Dabigatran	(2.3 Blood clots)
		Dalteparin	(2.3 Blood clots)
		Dantrolene	(10.3 Neuromuscular disorders)
		Dapagliflozin	(6.3 Diabetes mellitus and hypoglycaemia)
		Depo-Provera (Medroxyprogesterone 150mg vial)	(7.3 Contraception)
		Dermacool cream	(13.1 Dry and scaling skin disorders)
		Dermol 500 lotion	(13.1 Dry and scaling skin disorders)
		Dermol cream	(13.1 Dry and scaling skin disorders)
		Desmopressin	(6.1 Antidiuretic hormone disorders)
		Dexamethasone 0.1% / Hypromellose 0.5% / Neomycin 0.35% / Polymyxin B sulphate 6000units/mL eye drops/ointment (Maxitrol)	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Dexamethasone 0.1% / Neomycin 3250units/mL spray (Otomize)	(12.1 Ear)
		Dexamethasone 0.1% eye drops (brands include Maxidex)	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Dexamethasone	(16.2 Gastrointestinal symptoms- Palliative Care)
		Dextromethorphan sugar-free	(3.4 Cough and congestion)
		Diazepam	(10.3 Neuromuscular disorders)
		Diazepam	(15.1 General Anaesthesia)
		Diazepam	(16.4 Anxiety, depression and confusion- Palliative Care)
		Diazepam	(4.2 Mental health disorders)
		Diazepam	(4.8 Substance dependence)
		Diclofenac injection	(15.1 General Anaesthesia)
		Diethylstilbestrol (oral)	(8.2 Malignant disease)
		Diflucortolone 0.3% oily cream/ointment (Nerisone forte)	(13.3 Inflammatory skin conditions)
		Digoxin (oral)	(2.1 Arrhythmias)
		Digoxin	(2.1 Arrhythmias)
		Dimethyl sulfoxide (DMSO)	(7.2 Bladder installations and urological surgery)
		Dimeticone 4% lotion	(13.2 Infections of the skin)
		Disopyramide (oral)	(2.1 Arrhythmias)
		Docusate sodium (oral)	(1.2 Constipation and bowel cleansing)
		Docusate sodium	(16.2 Gastrointestinal symptoms- Palliative Care)
		Domperidone	(4.4 Nausea and labyrinth disorders)
		Dorzolamide 2% eye drops	(11.6 Treatment of glaucoma)
		Doxazosin standard-release	(7.1 Bladder and urinary disorders)
		Doxycycline (oral)	(5.2 Bacterial infection)
		Drapolene cream	(13.1 Dry and scaling skin disorders)
		Dulaglutide	(6.3 Diabetes mellitus and hypoglycaemia)
		E45 lotion	(13.1 Dry and scaling skin disorders)
		Elleste Duet (oral)	(6.8 Sex hormone responsive conditions)
		Elleste Solo (oral)	(6.8 Sex hormone responsive conditions)
		Empagliflozin	(6.3 Diabetes mellitus and hypoglycaemia)
		Emulsifying ointment	(13.1 Dry and scaling skin disorders)
		Enoxaparin	(2.3 Blood clots)
		Epimax ExCetra cream	(13.1 Dry and scaling skin disorders)
		Epimax Isomol gel	(13.1 Dry and scaling skin disorders)
		Epimax oatmeal cream	(13.1 Dry and scaling skin disorders)
		Epimax ointment	(13.1 Dry and scaling skin disorders)
		Epimax original cream	(13.1 Dry and scaling skin disorders)
		Epimax Paraffin-free ointment	(13.1 Dry and scaling skin disorders)
		Ertugliflozin	(6.3 Diabetes mellitus and hypoglycaemia)
		Erythromycin (oral)	(5.2 Bacterial infection)
		Espranor	(4.8 Substance dependence)
		Estradiol vaginal tablets 10micrograms	(7.6 Vaginal and vulval conditions)
		Estriol cream 0.1% (Ovestin)	(7.6 Vaginal and vulval conditions)
		Ethinylestradiol	(6.8 Sex hormone responsive conditions)
		Evorel Conti patch	(6.8 Sex hormone responsive conditions)
		Evorel patch	(6.8 Sex hormone responsive conditions)
		Evorel Sequi patch	(6.8 Sex hormone responsive conditions)
		Exorex lotion	(13.3 Inflammatory skin conditions)
		Ezetimibe	(2.6 Hyperlipidaemia)
		Famotidine	(1.4 Disorders of gastric acid and ulceration)
		Femoston - Conti (oral continuous)	(6.8 Sex hormone responsive conditions)
		Femoston 1/10, 2/10 tablets (oral)	(6.8 Sex hormone responsive conditions)
		FemSeven Conti patch	(6.8 Sex hormone responsive conditions)
		FemSeven patch	(6.8 Sex hormone responsive conditions)
		Ferrous fumarate	(9.1 Blood and blood–forming organs)
		Ferrous sulphate	(9.1 Blood and blood–forming organs)
		Finasteride	(6.8 Sex hormone responsive conditions)
		Finasteride	(7.1 Bladder and urinary disorders)
		Fleet Phospho-soda	(1.2 Constipation and bowel cleansing)
		Flucloxacillin (oral)	(5.2 Bacterial infection)
		Fluconazole (oral)	(5.3 Fungal infection)
		Fludrocortisone (oral)	(6.2 Corticosteroid responsive conditions)
		Fludroxycortide tape (Haelan)	(13.3 Inflammatory skin conditions)
		Flumazenil	(15.1 General Anaesthesia)
		Fluorescein 1% and 2% single-use eye drops	(11.8 Miscellaneous ophthalmic preparations)
		Fluorouracil cream (Efudix)	(13.5 Photodamage)
		Fluoxetine	(4.2 Mental health disorders)
		Fluticasone / Umeclidinium / Vilanterol (Trelegy Ellipta)	(3.1 Airways disease, obstructive)
		Fluticasone furoate / Vilanterol (Relvar Ellipta)	(3.1 Airways disease, obstructive)
		Fluticasone propionate / Formoterol (Flutiform inhaler, Flutiform k-haler)	(3.1 Airways disease, obstructive)
		Fluticasone propionate / Salmeterol (Combisal, Seretide and Sirdupla)	(3.1 Airways disease, obstructive)
		Folic acid	(9.1 Blood and blood–forming organs)
		Folinic acid (oral & parenteral)	(8.2 Malignant disease)
		Foodlink Complete Compact	(9.5 Nutrition)
		Foodlink Complete Fibre (4.5g)	(9.5 Nutrition)
		Foodlink Complete	(9.5 Nutrition)
		Formoterol (Atimos Modulite Formoterol Easyhaler)	(3.1 Airways disease, obstructive)
		Formoterol / Budesonide / Glycopyrronium (Trixeo) pressurised inhaler	(3.1 Airways disease, obstructive)
		Fosfomycin (oral & parenteral)	(5.2 Bacterial infection)
		Fresubin Thickened IDDSI Level 2 (1.6g)	(9.5 Nutrition)
		Furosemide	(2.8 Oedema)
		Fusidic acid 1% viscous eye drops	(11.3 Anti–infective eye preparations)
		Fusidic acid 2% cream (Fucidin)	(13.2 Infections of the skin)
		Gabapentin capsules	(16.1 Pain due to cancer in adults- Palliative Care)
		Gabapentin	(4.5 Pain)
		Gedarel 20/150	(7.3 Contraception)
		Gedarel 30/150	(7.3 Contraception)
		Gliclazide	(6.3 Diabetes mellitus and hypoglycaemia)
		Glucogel	(6.3 Diabetes mellitus and hypoglycaemia)
		Glucose infusion/injection 5%, 10%, 20%, 50%	(9.2 Fluid and electrolyte imbalances)
		Glycerine	(16.2 Gastrointestinal symptoms- Palliative Care)
		Glycerol (glycerin) suppositories	(1.2 Constipation and bowel cleansing)
		Glyceryl trinitrate 0.4% rectal ointment (Rectogesic)	(1.9 Rectal and anal disorders)
		Glyceryl trinitrate	(2.7 Myocardial ischaemia)
		Glycine 1.5% / Ethanol 1%	(7.2 Bladder installations and urological surgery)
		Haemophilus influenzae type B and Neisseria meningitides group C vaccine (Menitorix)	(14.4 Vaccination)
		Haloperidol (oral)	(4.2 Mental health disorders)
		Haloperidol	(16.2 Gastrointestinal symptoms- Palliative Care)
		Haloperidol	(16.4 Anxiety, depression and confusion- Palliative Care)
		Haloperidol	(16.6 End of life symptom control- Palliative Care)
		Hepatitis A / Hepatitis B vaccine (Twinrix)	(14.4 Vaccination)
		Hepatitis A and Typhoid combined	(14.4 Vaccination)
		Hepatitis A vaccine	(14.4 Vaccination)
		Hepatitis B vaccine	(14.4 Vaccination)
		Humalog	(6.3 Diabetes mellitus and hypoglycaemia)
		Human papillomavirus vaccine	(14.4 Vaccination)
		Humulin I	(6.3 Diabetes mellitus and hypoglycaemia)
		Humulin S	(6.3 Diabetes mellitus and hypoglycaemia)
		Hydralazine (oral)	(2.4 Blood pressure conditions)
		Hydrocortisone (intravenous use)	(1.1 Chronic bowel disorders)
		Hydrocortisone (oral)	(6.2 Corticosteroid responsive conditions)
		Hydrocortisone (parenteral)	(3.1 Airways disease, obstructive)
		Hydrocortisone (parenteral)	(6.2 Corticosteroid responsive conditions)
		Hydrocortisone 0.5, 1% cream/ointment	(13.3 Inflammatory skin conditions)
		Hydrocortisone 0.5% / Nystatin 100,000 units/g / Chlorhexidine hydrochloride 1% cream (Nystaform HC)	(13.3 Inflammatory skin conditions)
		Hydrocortisone 1% / Clotrimazole 1% cream (Canesten HC)	(13.3 Inflammatory skin conditions)
		Hydrocortisone 1% / Miconazole nitrate 2% cream/ointment (Daktacort)	(13.3 Inflammatory skin conditions)
		Hydrocortisone 2.5mg muco-adhesive buccal tablets	(12.3 Oropharynx)
		Hydrocortisone acetate (Hydrocortistab)	(10.5 Soft tissue and joint disorders)
		Hydrocortisone sodium succinate (parenteral)	(3.2 Allergic conditions)
		Hydrocortisone sodium succinate (Solucortef) (parenteral)	(6.2 Corticosteroid responsive conditions)
		Hydrogen peroxide 1% cream (Crystacide)	(13.9 Skin cleansers, antiseptics and desloughing agents)
		Hydrogen peroxide mouthwash 6%	(12.3 Oropharynx)
		Hydromol Intensive cream	(13.1 Dry and scaling skin disorders)
		Hydroxocobalamin intramuscular injection	(9.1 Blood and blood–forming organs)
		Hyoscine butyl bromide	(16.6 End of life symptom control- Palliative Care)
		Hyoscine hydrobromide patch	(4.4 Nausea and labyrinth disorders)
		Hyoscine hydrobromide transdermal as Scopoderm TTS Patch	(16.5 Mouthcare- Palliative Care)
		Hyoscine hydrobromide	(16.2 Gastrointestinal symptoms- Palliative Care)
		Hypromellose 0.3% or 0.5% eye drops	(11.8 Miscellaneous ophthalmic preparations)
		Ibuprofen 5% gel	(10.4 Pain and inflammation in musculoskeletal disorders)
		Ibuprofen	(10.4 Pain and inflammation in musculoskeletal disorders)
		Ibuprofen	(16.1 Pain due to cancer in adults- Palliative Care)
		Imiquimod cream (Aldara)	(13.12 Warts and calluses)
		Indapamide 2.5mg tablets	(2.4 Blood pressure conditions)
		Indapamide 2.5mg tablets	(2.8 Oedema)
		Influenza vaccine	(14.4 Vaccination)
		Insulatard	(6.3 Diabetes mellitus and hypoglycaemia)
		Intrauterine device (copper)	(7.3 Contraception)
		Ipratropium	(3.1 Airways disease, obstructive)
		Isosorbide mononitrate modified-release	(2.7 Myocardial ischaemia)
		Isosorbide mononitrate	(2.7 Myocardial ischaemia)
		Ispaghula husk (Fybogel)	(1.2 Constipation and bowel cleansing)
		Ketorolac 0.5% eye drops	(11.8 Miscellaneous ophthalmic preparations)
		Kliofem (oral continuous)	(6.8 Sex hormone responsive conditions)
		Kliovance (oral continuous)	(6.8 Sex hormone responsive conditions)
		Kyleena (Levonorgestrel intrauterine device)	(7.3 Contraception)
		Lactulose	(1.2 Constipation and bowel cleansing)
		Lactulose	(1.7 Liver disorders and related conditions)
		Lansoprazole capsules	(1.4 Disorders of gastric acid and ulceration)
		Latanoprost 50microgram/mL eye drops	(11.6 Treatment of glaucoma)
		Lenzetto transdermal spray	(6.8 Sex hormone responsive conditions)
		Levemir	(6.3 Diabetes mellitus and hypoglycaemia)
		Levest	(7.3 Contraception)
		Levonorgestrel 1500 micrograms (Levonelle 1500)	(7.3 Contraception)
		Levosert (Levonorgestrel intrauterine device)	(7.3 Contraception)
		Levothyroxine	(6.9 Thyroid disorders)
		Lidocaine 0.5%, 1% & 2% injection	(15.2 Local anaesthesia)
		Lidocaine 1% / Adrenaline 1 in 200,000 injection	(15.2 Local anaesthesia)
		Lidocaine 10% (10mg/dose) spray	(15.2 Local anaesthesia)
		Lidocaine 2.5% / Prilocaine 2.5% cream (Emla)	(15.2 Local anaesthesia)
		Lidocaine 2% / Adrenaline 1 in 200,000 injection	(15.2 Local anaesthesia)
		Lidocaine 2% / Adrenaline 1 in 80,000 cartridge	(15.2 Local anaesthesia)
		Lidocaine 2% / Adrenaline 1 in 80,000 self-aspirating cartridge	(15.2 Local anaesthesia)
		Lidocaine 2% / Chlorhexidine 0.25% gel	(15.2 Local anaesthesia)
		Lidocaine 2% gel	(15.2 Local anaesthesia)
		Lidocaine 4% cream (LMX 4)	(15.2 Local anaesthesia)
		Lidocaine 4% solution	(15.2 Local anaesthesia)
		Lidocaine 5% / Phenylephrine 0.5% topical solution	(15.2 Local anaesthesia)
		Lidocaine 5% ointment	(15.2 Local anaesthesia)
		Liquid paraffin eye ointment	(11.8 Miscellaneous ophthalmic preparations)
		Liquid paraffin with Vitamin A eye ointment	(11.8 Miscellaneous ophthalmic preparations)
		Lisinopril	(2.4 Blood pressure conditions)
		Lofepramine	(4.2 Mental health disorders)
		Loperamide capsules	(1.3 Diarrhoea)
		Loperamide	(16.2 Gastrointestinal symptoms- Palliative Care)
		Loratadine	(3.2 Allergic conditions)
		Lorazepam (parenteral)	(4.6 Seizures)
		Lorazepam	(15.1 General Anaesthesia)
		Lorazepam	(16.3 Respiratory symptoms- Palliative Care)
		Lorazepam	(16.4 Anxiety, depression and confusion- Palliative Care)
		Lorazepam	(4.4 Nausea and labyrinth disorders)
		Losartan	(2.4 Blood pressure conditions)
		Lymecycline (oral)	(5.2 Bacterial infection)
		Macrogol oral powder, compound	(1.2 Constipation and bowel cleansing)
		Macrogols	(16.2 Gastrointestinal symptoms- Palliative Care)
		Magnesium aspartate (Magnaspartate)	(9.2 Fluid and electrolyte imbalances)
		Magnesium glycerophosphate (Neomag)	(9.2 Fluid and electrolyte imbalances)
		Magnesium glycerophosphate oral solution	(9.2 Fluid and electrolyte imbalances)
		Magnesium hydroxide mixture, BP	(1.2 Constipation and bowel cleansing)
		Measles, Mumps and Rubella vaccine (MMR II)	(14.4 Vaccination)
		Mebendazole (oral)	(5.4 Helminth infection)
		Mebeverine 135mg tablets	(1.6 Gastro-intestinal smooth muscle spasm)
		Mebeverine 200mg modified-release capsules	(1.6 Gastro-intestinal smooth muscle spasm)
		Medroxyprogesterone acetate (oral)	(8.2 Malignant disease)
		Medroxyprogesterone	(6.8 Sex hormone responsive conditions)
		Megestrol (oral)	(8.2 Malignant disease)
		Menadiol sodium phosphate tablets	(9.6 Vitamin deficiencies)
		Meningococcal Group C conjugate vaccine	(14.4 Vaccination)
		Menthol in Aqueous cream 0.5%, 1% & 2%	(13.6 Pruritis)
		Mesalazine granules (Salofalk)	(1.1 Chronic bowel disorders)
		Mesna (oral & parenteral)	(8.2 Malignant disease)
		Metanium ointment	(13.1 Dry and scaling skin disorders)
		Metformin	(6.3 Diabetes mellitus and hypoglycaemia)
		Methadone	(4.8 Substance dependence)
		Methylprednisolone acetate (Depo-Medrone)	(10.5 Soft tissue and joint disorders)
		Methylprednisolone acetate / Lidocaine (Depo-Medrone with Lidocaine)	(10.5 Soft tissue and joint disorders)
		Metoclopramide	(1.6 Gastro-intestinal smooth muscle spasm)
		Metoclopramide	(16.2 Gastrointestinal symptoms- Palliative Care)
		Metoclopramide	(16.6 End of life symptom control- Palliative Care)
		Metoclopramide	(4.4 Nausea and labyrinth disorders)
		Metronidazole (oral & rectal)	(5.2 Bacterial infection)
		Metronidazole 0.75% cream/gel	(13.2 Infections of the skin)
		Metronidazole 0.75% cream/gel	(13.7 Rosacea and acne)
		Metronidazole 0.75% gel	(7.6 Vaginal and vulval conditions)
		Miconazole oral gel	(12.3 Oropharynx)
		Micronized Progesterone	(6.8 Sex hormone responsive conditions)
		Midazolam (buccal)	(4.6 Seizures)
		Midazolam	(15.1 General Anaesthesia)
		Midazolam	(16.6 End of life symptom control- Palliative Care)
		Mirena (Levonorgestrel intrauterine device)	(7.3 Contraception)
		Mirtazapine	(4.2 Mental health disorders)
		Mometasone furoate 0.1% cream/ointment (Elocon)	(13.3 Inflammatory skin conditions)
		Mometasone nasal spray	(12.2 Nose)
		Montelukast	(3.1 Airways disease, obstructive)
		Morphine sulfate (oral solution)	(4.5 Pain)
		Morphine sulfate (parenteral)	(4.5 Pain)
		Morphine sulphate injection	(16.1 Pain due to cancer in adults- Palliative Care)
		Morphine sulphate injection	(16.6 End of life symptom control- Palliative Care)
		Morphine	(16.1 Pain due to cancer in adults- Palliative Care)
		Mouthwash solution tablet	(12.3 Oropharynx)
		Moviprep	(1.2 Constipation and bowel cleansing)
		Multivitamin tablets	(9.6 Vitamin deficiencies)
		Mupirocin 2% cream/ointment	(13.2 Infections of the skin)
		Mupirocin 2% nasal ointment (Bactroban Nasal)	(12.2 Nose)
		Naloxone	(15.1 General Anaesthesia)
		Naproxen	(10.4 Pain and inflammation in musculoskeletal disorders)
		Naproxen	(16.1 Pain due to cancer in adults- Palliative Care)
		Neostigmine	(10.3 Neuromuscular disorders)
		Nexplanon (Etonogestrel 68mg per rod)	(7.3 Contraception)
		Nicorandil	(2.7 Myocardial ischaemia)
		Nicotine replacement therapy	(4.8 Substance dependence)
		Nitrofurantoin (oral)	(5.2 Bacterial infection)
		Nizatidine	(1.4 Disorders of gastric acid and ulceration)
		Noradrenaline (norepinephrine)	(2.4 Blood pressure conditions)
		Norethisterone (oral)	(8.2 Malignant disease)
		Norethisterone	(6.8 Sex hormone responsive conditions)
		Norimin	(7.3 Contraception)
		NPH Basal	(6.3 Diabetes mellitus and hypoglycaemia)
		Nutilis Clear	(9.5 Nutrition)
		Nutilis Complete Creme Level 3 (4g)	(9.5 Nutrition)
		Nutilis Complete Drink Level 3 (4g)	(9.5 Nutrition)
		Nutilis Fruit Level 4 (3.9g)	(9.5 Nutrition)
		Nutricrem (ready to eat)	(9.5 Nutrition)
		Nystatin oral suspension	(12.3 Oropharynx)
		Nystatin oral suspension	(16.5 Mouthcare- Palliative Care)
		Oestrogel gel (transdermal)	(6.8 Sex hormone responsive conditions)
		Oily Phenol Injection 5%	(1.9 Rectal and anal disorders)
		Olive oil	(12.1 Ear)
		Omeprazole 20mg bd, Amoxicillin 1g bd and Clarithromycin 500mg bd for 1 week	(1.4 Disorders of gastric acid and ulceration)
		Omeprazole capsules & intravenous infusion	(1.4 Disorders of gastric acid and ulceration)
		Ondansetron	(4.4 Nausea and labyrinth disorders)
		Oral morphine solution	(16.3 Respiratory symptoms- Palliative Care)
		Oral Rehydration Salts (ORS)	(9.2 Fluid and electrolyte imbalances)
		Orlistat	(1.8 Obesity)
		Ortho-phthalaldehyde solution 0.55% (Cidex OPA & NU - Cidex)	(13.9 Skin cleansers, antiseptics and desloughing agents)
		Oseltamivir (oral)	(5.6 Viral infection)
		Oxygen	(16.3 Respiratory symptoms- Palliative Care)
		Oxytetracycline (oral)	(5.2 Bacterial infection)
		Paracetamol - oral preparations	(16.1 Pain due to cancer in adults- Palliative Care)
		Paracetamol injection	(15.1 General Anaesthesia)
		Paracetamol	(4.5 Pain)
		Paravit-CF	(9.6 Vitamin deficiencies)
		Peak Flow Meter (standard range)	(3.1 Airways disease, obstructive)
		Peptac Liquid	(1.4 Disorders of gastric acid and ulceration)
		Perindopril erbumine	(2.4 Blood pressure conditions)
		Phenoxymethylpenicillin (oral)	(5.2 Bacterial infection)
		Phenylephrine 2.5% single-use eye drops	(11.5 Mydriatics and cycloplegics)
		Pholcodine	(3.4 Cough and congestion)
		Phosphate enema	(1.2 Constipation and bowel cleansing)
		Phosphate-Sandoz tablets	(9.2 Fluid and electrolyte imbalances)
		Phosphates polyfusor infusion	(9.2 Fluid and electrolyte imbalances)
		Phytomenadione (oral & parenteral)	(9.6 Vitamin deficiencies)
		Pilocarpine 1%, 2% or 4% eye drops	(11.6 Treatment of glaucoma)
		Pilocarpine tablets	(16.5 Mouthcare- Palliative Care)
		Pimecrolimus 1% cream (Elidel)	(13.3 Inflammatory skin conditions)
		Pioglitazone	(6.3 Diabetes mellitus and hypoglycaemia)
		Plenvu	(1.2 Constipation and bowel cleansing)
		Pneumococcal vaccine (Pneumovax II)	(14.4 Vaccination)
		Pneumococcal vaccine (Prevenar)	(14.4 Vaccination)
		Podophyllotoxin cream (Warticon)	(13.12 Warts and calluses)
		Polystyrene sulfonate resins	(9.2 Fluid and electrolyte imbalances)
		Potassium citrate BP	(7.1 Bladder and urinary disorders)
		Povidone iodine dry powder spray 2.5%	(13.9 Skin cleansers, antiseptics and desloughing agents)
		Povidone iodine ointment 10%	(13.9 Skin cleansers, antiseptics and desloughing agents)
		Pramipexole	(4.3 Movement disorders)
		Prednisolone (oral)	(1.1 Chronic bowel disorders)
		Prednisolone (oral)	(3.1 Airways disease, obstructive)
		Prednisolone 0.5% drops	(12.1 Ear)
		Prednisolone 0.5% eye drops (brands include Predsol)	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Prednisolone 1% eye drops (brands include Pred Forte)	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Prednisolone 5mg tablets (25mg tablets in specific patients) (oral)	(6.2 Corticosteroid responsive conditions)
		Prednisolone	(10.5 Soft tissue and joint disorders)
		Prilocaine 1% injection	(15.2 Local anaesthesia)
		Prilocaine 2% injection (Prilotekal)	(15.2 Local anaesthesia)
		Prochlorperazine	(4.4 Nausea and labyrinth disorders)
		Propranolol	(4.5 Pain)
		Pyridostigmine	(10.3 Neuromuscular disorders)
		Pyridoxine (oral)	(9.6 Vitamin deficiencies)
		Quinine (oral)	(5.5 Protozoal infection)
		Quinine sulphate	(10.3 Neuromuscular disorders)
		Rabies vaccine (Rabipur)	(14.4 Vaccination)
		Ramipril	(2.4 Blood pressure conditions)
		Respiratory Syncytial Virus (RSV) vaccine (Abrysvo)	(14.4 Vaccination)
		Rigevidon	(7.3 Contraception)
		Risperidone	(4.2 Mental health disorders)
		Rivaroxaban	(2.3 Blood clots)
		Salbutamol (inhaled & nebulised)	(3.1 Airways disease, obstructive)
		Salicylic acid / Lactic acid paint (Salactol)	(13.12 Warts and calluses)
		Salivary substitutes	(16.5 Mouthcare- Palliative Care)
		Salmeterol	(3.1 Airways disease, obstructive)
		Salofalk retention enema/suppositories/foam enema	(1.1 Chronic bowel disorders)
		Sando K	(9.2 Fluid and electrolyte imbalances)
		Sandrena gel (transdermal)	(6.8 Sex hormone responsive conditions)
		Sayana Press (Medroxyprogesterone 104mg single dose injector device)	(7.3 Contraception)
		Scheriproct ointment & suppositories	(1.9 Rectal and anal disorders)
		Sebco scalp ointment	(13.3 Inflammatory skin conditions)
		Semaglutide (injectable)	(6.3 Diabetes mellitus and hypoglycaemia)
		Semglee	(6.3 Diabetes mellitus and hypoglycaemia)
		Senna	(1.2 Constipation and bowel cleansing)
		Senna	(16.2 Gastrointestinal symptoms- Palliative Care)
		Sertraline	(16.4 Anxiety, depression and confusion- Palliative Care)
		Sertraline	(4.2 Mental health disorders)
		Sildenafil	(7.4 Erectile and ejaculatory conditions)
		Silver nitrate application	(13.12 Warts and calluses)
		Silver sulfadiazine (sulphadiazine) 1% cream (Flamazine)	(13.2 Infections of the skin)
		Simple linctus	(3.4 Cough and congestion)
		Simple linctus	(16.3 Respiratory symptoms- Palliative Care)
		Sitagliptin	(6.3 Diabetes mellitus and hypoglycaemia)
		Sodium bicarbonate 5% drops	(12.1 Ear)
		Sodium bicarbonate 500mg capsules	(9.2 Fluid and electrolyte imbalances)
		Sodium bicarbonate injection/infusion 1.26%, 2.7%, 8.4%	(9.2 Fluid and electrolyte imbalances)
		Sodium bicarbonate	(7.1 Bladder and urinary disorders)
		Sodium chloride 0.18% / glucose 4% intravenous infusion	(9.2 Fluid and electrolyte imbalances)
		Sodium chloride 0.45% / glucose 2.5% intravenous infusion	(9.2 Fluid and electrolyte imbalances)
		Sodium chloride 0.45% / glucose 5% intravenous infusion	(9.2 Fluid and electrolyte imbalances)
		Sodium chloride 0.9% used as diluent	(3.1 Airways disease, obstructive)
		Sodium chloride 0.9%	(7.2 Bladder installations and urological surgery)
		Sodium chloride injection / infusion 0.45%, 0.9%, 1.8%	(9.2 Fluid and electrolyte imbalances)
		Sodium chloride modified-release (Slow Sodium)	(9.2 Fluid and electrolyte imbalances)
		Sodium citrate (Micralax)	(16.2 Gastrointestinal symptoms- Palliative Care)
		Sodium cromoglicate 2% eye drops	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Sodium cromoglicate pMDI	(3.1 Airways disease, obstructive)
		Sodium hyaluronate	(7.2 Bladder installations and urological surgery)
		Sodium lactate intravenous infusion compound (Hartmann's solution)	(9.2 Fluid and electrolyte imbalances)
		Sodium picosulphate with magnesium citrate (Picolax, CitraFleet)	(1.2 Constipation and bowel cleansing)
		Solifenacin	(7.1 Bladder and urinary disorders)
		Sotalol (oral)	(2.1 Arrhythmias)
		Standard inhaler (pMDI) and spacer	(3.1 Airways disease, obstructive)
		Sudocrem cream	(13.1 Dry and scaling skin disorders)
		Sumatriptan (subcutaneous injection)	(4.5 Pain)
		Sumatriptan	(4.5 Pain)
		Tacrolimus 0.03% and 0.1% ointment (Protopic)	(13.3 Inflammatory skin conditions)
		Tamsulosin capsules modified-release	(7.1 Bladder and urinary disorders)
		Temazepam	(15.1 General Anaesthesia)
		Temazepam	(4.7 Sleep disorders)
		Terbinafine (oral)	(5.3 Fungal infection)
		Terbinafine 1% cream (Lamisil)	(13.2 Infections of the skin)
		Testosterone gel	(6.8 Sex hormone responsive conditions)
		Tetracaine 4% gel (Ametop)	(15.2 Local anaesthesia)
		Thiamine (oral)	(9.6 Vitamin deficiencies)
		Thickened IDDSI Level 3 (1.6g)	(9.5 Nutrition)
		Tibolone	(6.8 Sex hormone responsive conditions)
		Timolol 0.25% or 0.5% eye drops	(11.6 Treatment of glaucoma)
		Tinzaparin	(2.3 Blood clots)
		Tirzepatide	(6.3 Diabetes mellitus and hypoglycaemia)
		Tizanidine	(10.3 Neuromuscular disorders)
		Tranexamic Acid	(2.2 Bleeding disorders)
		Travoprost 40microgram/mL eye drops	(11.6 Treatment of glaucoma)
		Tretinoin 0.025% / Clindamycin 1% Gel	(13.7 Rosacea and acne)
		Triamcinolone acetonide (Kenalog)	(10.5 Soft tissue and joint disorders)
		Trifarotene cream 50micrograms/g (Aklief)	(13.7 Rosacea and acne)
		Trimethoprim (oral)	(5.2 Bacterial infection)
		Trimethoprim (oral)	(5.3 Fungal infection)
		Tristel multishot	(13.9 Skin cleansers, antiseptics and desloughing agents)
		Tropicamide 0.5% or 1% eye drops	(11.5 Mydriatics and cycloplegics)
		Trurapi	(6.3 Diabetes mellitus and hypoglycaemia)
		Tuberculin PPD RT 23 SSI, 2 T.U./0.1 mL	(14.3 Tuberculosis diagnostic test)
		Typhoid vaccine	(14.4 Vaccination)
		Ulipristal acetate (EllaOne)	(7.3 Contraception)
		Ursodeoxycholic acid	(1.7 Liver disorders and related conditions)
		Valupack Vitamin E capsules	(9.6 Vitamin deficiencies)
		Vancomycin (oral)	(5.2 Bacterial infection)
		Varenicline	(4.8 Substance dependence)
		Varicella-Zoster vaccine (Zostavax or Shingrix)	(14.4 Vaccination)
		Venlafaxine	(4.2 Mental health disorders)
		Verapamil (oral)	(2.1 Arrhythmias)
		Vitamin A+D	(9.6 Vitamin deficiencies)
		Vitamin B compound strong (oral)	(9.6 Vitamin deficiencies)
		Warfarin	(2.3 Blood clots)
		White soft paraffin in liquid paraffin (50:50)	(13.1 Dry and scaling skin disorders)
		Xylometazoline 0.1% drops/spray	(12.2 Nose)
		Yes! vaginal moisturiser	(7.6 Vaginal and vulval conditions)
		Zanamivir (oral)	(5.6 Viral infection)
		Zelleta	(7.3 Contraception)
		ZeroAQS cream	(13.1 Dry and scaling skin disorders)
		Zerocream	(13.1 Dry and scaling skin disorders)
		Zinc paste bandages (Ichthopaste, Viscopaste, Zipzoc)	(13.3 Inflammatory skin conditions)
		Zinc sulphate (45mg zinc) effervescent tablets (Solvazinc)	(9.4 Trace element deficiencies)
		Zomorph Morphine modified release capsules	(4.5 Pain)
		Zopiclone	(4.7 Sleep disorders)

Adult Second line drugs:

		Abasaglar	(6.3 Diabetes mellitus and hypoglycaemia)
		Abidec / Dalivit	(9.6 Vitamin deficiencies)
		Acamprosate	(4.8 Substance dependence)
		Acetazolamide 250mg tablets	(2.8 Oedema)
		Acetazolamide immediate & modified release (oral)	(11.6 Treatment of glaucoma)
		Acetylcysteine 5% eye drops	(11.8 Miscellaneous ophthalmic preparations)
		Aclidinium (Eklira Genuair)	(3.1 Airways disease, obstructive)
		Actimorph orodispersible tablets	(4.5 Pain)
		Adex gel	(13.1 Dry and scaling skin disorders)
		Alfentanil injection 500micrograms/mL, 5mg/mL	(16.1 Pain due to cancer in adults- Palliative Care)
		Alfentanil injection	(16.6 End of life symptom control- Palliative Care)
		Alfentanil nasal / buccal / sublingual spray	(16.1 Pain due to cancer in adults- Palliative Care)
		Alfuzosin modified-release	(7.1 Bladder and urinary disorders)
		Allpresan diabetic intensive foam cream (10% urea)	(13.1 Dry and scaling skin disorders)
		Almotriptan	(4.5 Pain)
		Alogliptin	(6.3 Diabetes mellitus and hypoglycaemia)
		Altrajuce	(9.5 Nutrition)
		Altraplen Compact Daily	(9.5 Nutrition)
		Altraplen Compact	(9.5 Nutrition)
		Altraplen Protein	(9.5 Nutrition)
		Alverine citrate	(1.6 Gastro-intestinal smooth muscle spasm)
		Amisulpride	(4.2 Mental health disorders)
		Amitriptyline	(4.2 Mental health disorders)
		Amitriptyline	(4.5 Pain)
		Amorolfine 5% nail solution (Loceryl)	(13.2 Infections of the skin)
		Amoxicillin (parenteral)	(5.2 Bacterial infection)
		Analogue Basal	(6.3 Diabetes mellitus and hypoglycaemia)
		Antacids	(16.2 Gastrointestinal symptoms- Palliative Care)
		Antibiotics	(16.3 Respiratory symptoms- Palliative Care)
		Apraclonidine 1% eye drops	(11.8 Miscellaneous ophthalmic preparations)
		AproDerm colloidal oat cream (Paraffin-free)	(13.1 Dry and scaling skin disorders)
		Aproderm emollient cream	(13.1 Dry and scaling skin disorders)
		Aproderm gel	(13.1 Dry and scaling skin disorders)
		Arachis oil	(16.2 Gastrointestinal symptoms- Palliative Care)
		Artificial saliva spray (Glandosane, AS Saliva Orthana)	(12.3 Oropharynx)
		Asacol modified-release tablets	(1.1 Chronic bowel disorders)
		Atenolol	(6.9 Thyroid disorders)
		Axsain cream	(4.5 Pain)
		Aymes ActaGain 600	(9.5 Nutrition)
		Aymes ActaGain Juce	(9.5 Nutrition)
		Aymes Complete	(9.5 Nutrition)
		Azithromycin (oral)	(5.2 Bacterial infection)
		Baclofen	(16.2 Gastrointestinal symptoms- Palliative Care)
		Beclometasone / Formoterol / Glycopyrronium (Trimbow pMDI)	(3.1 Airways disease, obstructive)
		Beclometasone dipropionate (Clipper)	(1.1 Chronic bowel disorders)
		Bempedoic Acid	(2.6 Hyperlipidaemia)
		Bendroflumethiazide 2.5mg tablets	(2.8 Oedema)
		Benztropine	(4.3 Movement disorders)
		Benzylpenicillin sodium (parenteral)	(5.2 Bacterial infection)
		Betamethasone 0.1% eye drops	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Bezafibrate	(2.6 Hyperlipidaemia)
		Bimatoprost 0.03% / Timolol 0.5% eye drops (brands include Ganfort)	(11.6 Treatment of glaucoma)
		Bimatoprost 100microgram/mL and 300microgram/mL eye drops	(11.6 Treatment of glaucoma)
		Bisacodyl	(1.2 Constipation and bowel cleansing)
		Brimonidine 0.2% / Timolol 0.5% eye drops (brands include Combigan)	(11.6 Treatment of glaucoma)
		Brinzolamide 10mg / Timolol 5mg/mL eye drops (brands include Azarga)	(11.6 Treatment of glaucoma)
		Bromocriptine	(4.3 Movement disorders)
		Budesonide (inhaled & nebulised)	(3.1 Airways disease, obstructive)
		Budesonide nasal spray	(12.2 Nose)
		Bumetanide	(2.8 Oedema)
		Buprenorphine patches	(4.5 Pain)
		Buprenorphine transdermal patches	(16.1 Pain due to cancer in adults- Palliative Care)
		Bupropion Hydrochloride	(4.8 Substance dependence)
		Calcichew (calcium carbonate) chewable tablet	(9.2 Fluid and electrolyte imbalances)
		Calcium 500 (calcium carbonate) tablet	(9.2 Fluid and electrolyte imbalances)
		Calcium acetate (Phosex)	(9.2 Fluid and electrolyte imbalances)
		Candesartan	(4.5 Pain)
		Carbamazepine	(4.5 Pain)
		Carbocisteine	(16.3 Respiratory symptoms- Palliative Care)
		Carbomer 980 gel	(11.8 Miscellaneous ophthalmic preparations)
		Carmellose sodium eye drops	(11.8 Miscellaneous ophthalmic preparations)
		Carvedilol	(2.4 Blood pressure conditions)
		Cefalexin (oral)	(5.2 Bacterial infection)
		Cefixime (oral)	(5.2 Bacterial infection)
		Ceftriaxone (parenteral)	(5.2 Bacterial infection)
		Celecoxib	(10.4 Pain and inflammation in musculoskeletal disorders)
		Cerazette	(7.3 Contraception)
		Cerelle	(7.3 Contraception)
		Cetraben ointment	(13.1 Dry and scaling skin disorders)
		Chlorpromazine	(16.2 Gastrointestinal symptoms- Palliative Care)
		Chlorpromazine	(4.2 Mental health disorders)
		Chlorthalidone	(2.8 Oedema)
		Ciclesonide (inhaled)	(3.1 Airways disease, obstructive)
		Cilique	(7.3 Contraception)
		Cimetidine	(1.4 Disorders of gastric acid and ulceration)
		Ciprofloxacin 0.3% / Dexamethasone 0.1%	(12.1 Ear)
		Clindamycin (oral)	(5.2 Bacterial infection)
		Clobetasone butyrate 0.05% / Oxytetracycline 3% / Nystatin 100,000 units/g cream (Trimovate)	(13.3 Inflammatory skin conditions)
		Clomifene	(6.8 Sex hormone responsive conditions)
		Clonazepam tablets / injection for subcutaneous use	(16.1 Pain due to cancer in adults- Palliative Care)
		Clonazepam	(4.5 Pain)
		Clonidine	(2.4 Blood pressure conditions)
		Clotrimazole 1% solution	(12.1 Ear)
		Co-amilofruse	(2.8 Oedema)
		Co-amoxiclav (oral)	(5.2 Bacterial infection)
		Co-danthramer strong	(1.2 Constipation and bowel cleansing)
		Co-danthramer	(1.2 Constipation and bowel cleansing)
		Co-magaldrox 195/220 suspension (Mucogel - low in sodium)	(1.4 Disorders of gastric acid and ulceration)
		Co-trimoxazole (oral)	(5.2 Bacterial infection)
		Codeine linctus	(3.4 Cough and congestion)
		Codeine phosphate	(16.2 Gastrointestinal symptoms- Palliative Care)
		Corticosteroids	(4.5 Pain)
		Creon	(16.2 Gastrointestinal symptoms- Palliative Care)
		Cyanocobalamin	(9.1 Blood and blood–forming organs)
		Daridorexant	(4.7 Sleep disorders)
		Demeclocycline hydrochloride (oral)	(5.2 Bacterial infection)
		Dermatonics Dry Skin Balm (10% urea)	(13.1 Dry and scaling skin disorders)
		Dermatonics Once Heel Balm (25% urea)	(13.1 Dry and scaling skin disorders)
		Dexamethasone (oral & parenteral)	(6.2 Corticosteroid responsive conditions)
		Dexamethasone 0.05% / Framycetin 0.5% / Gramicidin 0.005% drops (Sofradex)	(12.1 Ear)
		Dexamethasone	(16.1 Pain due to cancer in adults- Palliative Care)
		Dexamethasone	(16.2 Gastrointestinal symptoms- Palliative Care)
		Dexamethasone	(16.3 Respiratory symptoms- Palliative Care)
		Dexamethasone	(4.4 Nausea and labyrinth disorders)
		Diamorphine injection	(16.1 Pain due to cancer in adults- Palliative Care)
		Diamorphine injection	(16.6 End of life symptom control- Palliative Care)
		Diamorphine	(4.5 Pain)
		Diazepam	(16.2 Gastrointestinal symptoms- Palliative Care)
		Diclofenac 3% gel (Solaraze)	(13.5 Photodamage)
		Diclofenac	(10.4 Pain and inflammation in musculoskeletal disorders)
		Diclofenac	(16.1 Pain due to cancer in adults- Palliative Care)
		Dihydrocodeine	(4.5 Pain)
		Diltiazem 2% ointment or cream (unlicensed)	(1.9 Rectal and anal disorders)
		Diltiazem modified-release	(2.4 Blood pressure conditions)
		Dipyridamole modified-release in combination with aspirin	(2.3 Blood clots)
		Dipyridamole	(2.3 Blood clots)
		Disulfiram	(4.8 Substance dependence)
		Domperidone tablets / suppositories	(16.2 Gastrointestinal symptoms- Palliative Care)
		Domperidone	(1.6 Gastro-intestinal smooth muscle spasm)
		Domperidone	(16.2 Gastrointestinal symptoms- Palliative Care)
		Donepezil	(4.1 Dementia)
		Dorzolamide 2% / Timolol 0.5% eye drops	(11.6 Treatment of glaucoma)
		Dosulepin	(4.5 Pain)
		Doublebase Once gel	(13.1 Dry and scaling skin disorders)
		Doxazosin	(2.4 Blood pressure conditions)
		Dretine	(7.3 Contraception)
		Duloxetine	(4.5 Pain)
		Dutasteride	(6.8 Sex hormone responsive conditions)
		Dutasteride	(7.1 Bladder and urinary disorders)
		Edoxaban	(2.3 Blood clots)
		Eflornithine 11.5% cream	(13.8 Scalp and hair conditions)
		Emollin	(13.1 Dry and scaling skin disorders)
		Ensure Compact	(9.5 Nutrition)
		Erythromycin (oral)	(5.2 Bacterial infection)
		Escitalopram	(4.2 Mental health disorders)
		Esomeprazole granules	(1.4 Disorders of gastric acid and ulceration)
		Esomeprazole tablets/capsules	(1.4 Disorders of gastric acid and ulceration)
		Estradot patch	(6.8 Sex hormone responsive conditions)
		Estring Vaginal Ring	(7.6 Vaginal and vulval conditions)
		Ethinylestradiol / Norelgestromin patch (Evra)	(7.3 Contraception)
		Etodolac	(10.4 Pain and inflammation in musculoskeletal disorders)
		Etoricoxib	(10.4 Pain and inflammation in musculoskeletal disorders)
		Exenatide	(6.3 Diabetes mellitus and hypoglycaemia)
		Famciclovir (oral)	(5.6 Viral infection)
		Febuxostat	(10.2 Hyperuricaemia and gout)
		Felodipine modified-release	(2.4 Blood pressure conditions)
		Femodene ED	(7.3 Contraception)
		Fenofibrate (micronised or modified-release)	(2.6 Hyperlipidaemia)
		Fentanyl citrate injection for subcutaneous use	(16.1 Pain due to cancer in adults- Palliative Care)
		Fentanyl injection	(16.6 End of life symptom control- Palliative Care)
		Fentanyl injection	(4.5 Pain)
		Fentanyl lozenges	(4.5 Pain)
		Fentanyl patches	(4.5 Pain)
		Fentanyl subcutaneous injection	(16.3 Respiratory symptoms- Palliative Care)
		Fentanyl sublingual tablets (Abstral)	(16.1 Pain due to cancer in adults- Palliative Care)
		Fentanyl sublingual tablets	(4.5 Pain)
		Fentanyl transdermal patches	(16.1 Pain due to cancer in adults- Palliative Care)
		Fentanyl	(16.1 Pain due to cancer in adults- Palliative Care)
		Ferric maltol capsules (Feraccru)	(9.1 Blood and blood–forming organs)
		Ferrous fumarate / Folic acid tablet (Pregaday)	(9.1 Blood and blood–forming organs)
		Ferrous gluconate tablet	(9.1 Blood and blood–forming organs)
		Fexofenadine	(3.2 Allergic conditions)
		Flucloxacillin (parenteral)	(5.2 Bacterial infection)
		Fluconazole capsules/oral suspension	(16.5 Mouthcare- Palliative Care)
		Flumetasone pivalate 0.02% / Clioquinol 1% drops (Locorten-Vioform)	(12.1 Ear)
		Fluocinolone 0.00625%	(13.3 Inflammatory skin conditions)
		Fluocinolone acetonide 0.025% gel/ointment/cream (Synalar)	(13.3 Inflammatory skin conditions)
		Fluorometholone 0.1% eye drops	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Fluorouracil 0.5% and Salicylic acid 10% (Actikerall)	(13.5 Photodamage)
		Fluticasone (inhaled & nebulised)	(3.1 Airways disease, obstructive)
		Fluticasone furoate spray (Avamys)	(12.2 Nose)
		Fluticasone nasal drops	(12.2 Nose)
		Fluvoxamine	(4.2 Mental health disorders)
		Formoterol / Aclidinium (Duaklir Genuair)	(3.1 Airways disease, obstructive)
		Formoterol / Glycopyrronium (Bevespi Aerosphere)	(3.1 Airways disease, obstructive)
		Fortisip Compact Fibre (4.5g)	(9.5 Nutrition)
		Fortisip Compact	(9.5 Nutrition)
		Fortisip	(9.5 Nutrition)
		Furosemide	(16.3 Respiratory symptoms- Palliative Care)
		Galantamine - includes prolonged-release capsules	(4.1 Dementia)
		Gelclair gel	(12.3 Oropharynx)
		Gelclair gel	(16.5 Mouthcare- Palliative Care)
		Gentamicin (parenteral)	(5.2 Bacterial infection)
		Gentamicin 0.3% eye drops	(11.3 Anti–infective eye preparations)
		Glimepiride	(6.3 Diabetes mellitus and hypoglycaemia)
		Glucagon	(6.3 Diabetes mellitus and hypoglycaemia)
		Glucose (parenteral)	(6.3 Diabetes mellitus and hypoglycaemia)
		Glycopyrronium (Seebri Breezhaler)	(3.1 Airways disease, obstructive)
		Glycopyrronium bromide	(16.5 Mouthcare- Palliative Care)
		Glycopyrronium bromide	(16.6 End of life symptom control- Palliative Care)
		Griseofulvin (oral)	(5.3 Fungal infection)
		Haloperidol tablets / liquid / capsules / subcutaneous injection	(16.2 Gastrointestinal symptoms- Palliative Care)
		Haloperidol	(16.6 End of life symptom control- Palliative Care)
		Haloperidol	(4.4 Nausea and labyrinth disorders)
		Humalog (KwikPen 200 units/mL)	(6.3 Diabetes mellitus and hypoglycaemia)
		Hyaluronidase	(10.5 Soft tissue and joint disorders)
		Hydrocortisone 1% / Gentamicin 0.3% drops (Gentisone HC)	(12.1 Ear)
		Hydromorphone injection	(16.1 Pain due to cancer in adults- Palliative Care)
		Hydromorphone	(16.1 Pain due to cancer in adults- Palliative Care)
		Hydromorphone	(4.5 Pain)
		Hydroxyzine	(3.2 Allergic conditions)
		Hyoscine butylbromide	(1.6 Gastro-intestinal smooth muscle spasm)
		Hyoscine hydrobromide transdermal patch	(16.2 Gastrointestinal symptoms- Palliative Care)
		Hyoscine hydrobromide	(16.6 End of life symptom control- Palliative Care)
		Ibandronic acid 150mg tablet	(6.4 Disorders of bone metabolism)
		Icosapent ethyl	(2.6 Hyperlipidaemia)
		Inclisiran	(2.6 Hyperlipidaemia)
		Indacaterol (Onbrez Breezhaler)	(3.1 Airways disease, obstructive)
		Indacaterol / Glycopyrronium (UltiBro Breezhaler)	(3.1 Airways disease, obstructive)
		Indapamide 1.5mg modified-release tablets	(2.8 Oedema)
		Indometacin	(10.4 Pain and inflammation in musculoskeletal disorders)
		Ipratropium 0.03% spray (Rinatec)	(12.2 Nose)
		Irbesartan	(2.4 Blood pressure conditions)
		Itraconazole (oral)	(5.3 Fungal infection)
		Itraconazole capsules/oral liquid	(16.5 Mouthcare- Palliative Care)
		Ivermectin (oral)	(13.2 Infections of the skin)
		Ivermectin cream	(13.7 Rosacea and acne)
		Jaydess (Levonorgestrel intrauterine device)	(7.3 Contraception)
		Ketoconazole 2% cream (Nizoral)	(13.2 Infections of the skin)
		Ketotifen eye drops	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Labetalol (oral)	(2.4 Blood pressure conditions)
		Lamotrigine	(4.5 Pain)
		Lansoprazole fastabs	(1.4 Disorders of gastric acid and ulceration)
		Lantus	(6.3 Diabetes mellitus and hypoglycaemia)
		Latanoprost 50micrograms / Timolol 5mg/mL (brands include Xalacom)	(11.6 Treatment of glaucoma)
		Lercanidipine	(2.4 Blood pressure conditions)
		Levemir	(6.3 Diabetes mellitus and hypoglycaemia)
		Levobunolol 0.5% eye drops	(11.6 Treatment of glaucoma)
		Levofloxacin (oral)	(5.2 Bacterial infection)
		Levofloxacin 0.5% eye drops	(11.3 Anti–infective eye preparations)
		Levomepromazine	(4.4 Nausea and labyrinth disorders)
		Levomepromazine 6mg tablets (unlicensed)/25mg subcutaneous injection	(16.2 Gastrointestinal symptoms- Palliative Care)
		Levomepromazine subcutaneous injection	(16.6 End of life symptom control- Palliative Care)
		Levomepromazine	(16.6 End of life symptom control- Palliative Care)
		Lidocaine patch	(4.5 Pain)
		Linagliptin	(6.3 Diabetes mellitus and hypoglycaemia)
		Liraglutide (Victoza)	(6.3 Diabetes mellitus and hypoglycaemia)
		Lixisenatide	(6.3 Diabetes mellitus and hypoglycaemia)
		Lizinna	(7.3 Contraception)
		Lofexidine	(4.8 Substance dependence)
		Loperamide tablets	(1.3 Diarrhoea)
		Lorazepam	(4.2 Mental health disorders)
		Lorazepam	(4.8 Substance dependence)
		Macrogols	(16.2 Gastrointestinal symptoms- Palliative Care)
		Magnesium oxide capsules	(9.2 Fluid and electrolyte imbalances)
		Malathion 0.5% liquid	(13.2 Infections of the skin)
		Mannitol (Osmohale) capsules	(3.6 Respiratory depression, respiratory distress syndrome and apnoea)
		Marvelon	(7.3 Contraception)
		Mefenamic acid	(10.4 Pain and inflammation in musculoskeletal disorders)
		Meloxicam	(10.4 Pain and inflammation in musculoskeletal disorders)
		Memantine	(4.1 Dementia)
		Meningococcal Group B vaccine (Bexsero)	(14.4 Vaccination)
		Meningococcal Groups A, C, W135 and Y Conjugate vaccine (Menveo or Nimenrix)	(14.4 Vaccination)
		Mercilon	(7.3 Contraception)
		Metformin modified-release	(6.3 Diabetes mellitus and hypoglycaemia)
		Methadone linctus	(16.3 Respiratory symptoms- Palliative Care)
		Methadone linctus	(3.4 Cough and congestion)
		Methadone	(16.1 Pain due to cancer in adults- Palliative Care)
		Methadone	(4.5 Pain)
		Methenamine (oral)	(5.2 Bacterial infection)
		Methylcellulose	(1.2 Constipation and bowel cleansing)
		Methyldopa	(2.4 Blood pressure conditions)
		Methylnaltrexone	(1.2 Constipation and bowel cleansing)
		Methylnaltrexone	(16.2 Gastrointestinal symptoms- Palliative Care)
		Methylprednisolone (oral)	(6.2 Corticosteroid responsive conditions)
		Methylprednisolone (parenteral)	(6.2 Corticosteroid responsive conditions)
		Methylprednisolone sodium succinate	(1.1 Chronic bowel disorders)
		Methylprednisolone	(10.5 Soft tissue and joint disorders)
		Metoclopramide	(16.3 Respiratory symptoms- Palliative Care)
		Metolazone	(2.8 Oedema)
		Metoprolol	(2.4 Blood pressure conditions)
		Metyrapone	(6.2 Corticosteroid responsive conditions)
		Mezavant XL	(1.1 Chronic bowel disorders)
		Miconazole 2% cream (Daktarin)	(13.2 Infections of the skin)
		Microgynon 30	(7.3 Contraception)
		Microgynon ED	(7.3 Contraception)
		Midazolam	(16.4 Anxiety, depression and confusion- Palliative Care)
		Millinette 20/75	(7.3 Contraception)
		Millinette 30/75	(7.3 Contraception)
		Minoxidil	(2.4 Blood pressure conditions)
		Mirabegron	(7.1 Bladder and urinary disorders)
		Mirtazapine	(16.4 Anxiety, depression and confusion- Palliative Care)
		Moclobemide	(4.2 Mental health disorders)
		Morphine	(3.4 Cough and congestion)
		Moxifloxacin (oral)	(5.2 Bacterial infection)
		Moxonidine	(2.4 Blood pressure conditions)
		Nabumetone	(10.4 Pain and inflammation in musculoskeletal disorders)
		Nadolol	(2.4 Blood pressure conditions)
		Naftidrofuryl oxalate	(2.9 Vascular disease)
		Naldemedine	(1.2 Constipation and bowel cleansing)
		Naloxegol	(1.2 Constipation and bowel cleansing)
		Naratriptan	(4.5 Pain)
		Nebivolol	(2.4 Blood pressure conditions)
		Nifedipine capsules non modified-release	(2.4 Blood pressure conditions)
		Nifedipine modified-release	(2.4 Blood pressure conditions)
		Norgeston	(7.3 Contraception)
		Nortriptyline	(4.5 Pain)
		Novorapid	(6.3 Diabetes mellitus and hypoglycaemia)
		Nutrizym 22 Capsules	(1.10 Reduced exocrine secretions)
		Nystatin cream/ointment (Nystan)	(13.2 Infections of the skin)
		Octasa modified-release	(1.1 Chronic bowel disorders)
		Octenidine 0.3% Lotion (Octenisan)	(13.9 Skin cleansers, antiseptics and desloughing agents)
		Octreotide	(16.2 Gastrointestinal symptoms- Palliative Care)
		Ofloxacin (oral)	(5.2 Bacterial infection)
		Olanzapine (oral)	(4.2 Mental health disorders)
		Olanzapine	(16.4 Anxiety, depression and confusion- Palliative Care)
		Olodaterol (Striverdi Respimat)	(3.1 Airways disease, obstructive)
		Olodaterol / Tiotropium (inhaled) (Spiolto Respimat)	(3.1 Airways disease, obstructive)
		Olopatadine 1mg/mL eye drops	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Olsalazine	(1.1 Chronic bowel disorders)
		Omeprazole 20mg bd, Metronidazole 400mg bd and Clarithromycin 500mg bd for 1 week	(1.4 Disorders of gastric acid and ulceration)
		Omeprazole dispersible gastro-resistant tablets	(1.4 Disorders of gastric acid and ulceration)
		Omeprazole	(16.2 Gastrointestinal symptoms- Palliative Care)
		Ondansetron subcutaneous/intravenous injection	(16.6 End of life symptom control- Palliative Care)
		Ondansetron tablets / injection	(16.2 Gastrointestinal symptoms- Palliative Care)
		Oral morphine solution	(16.3 Respiratory symptoms- Palliative Care)
		Orphenadrine	(4.3 Movement disorders)
		Other Inhaler	(3.1 Airways disease, obstructive)
		Ovranette	(7.3 Contraception)
		Oxazepam	(4.8 Substance dependence)
		Oxybutynin standard-release	(7.1 Bladder and urinary disorders)
		Oxybutynin (transdermal)	(7.1 Bladder and urinary disorders)
		Oxybutynin modified release	(7.1 Bladder and urinary disorders)
		Oxycodone (oral)	(4.5 Pain)
		Oxycodone injection 50mg/mL for subcutaneous use	(16.1 Pain due to cancer in adults- Palliative Care)
		Oxycodone injection	(16.6 End of life symptom control- Palliative Care)
		Oxycodone liquid	(16.3 Respiratory symptoms- Palliative Care)
		Oxycodone	(16.1 Pain due to cancer in adults- Palliative Care)
		Pancrex V Capsules	(1.10 Reduced exocrine secretions)
		Pancrex V Powder	(1.10 Reduced exocrine secretions)
		Pantoprazole (intravenous)	(1.4 Disorders of gastric acid and ulceration)
		Paracetamol (intravenous & rectal)	(16.1 Pain due to cancer in adults- Palliative Care)
		Paroxetine	(4.2 Mental health disorders)
		Pentasa tablets, granules modified-release	(1.1 Chronic bowel disorders)
		Perindopril erbumine	(2.4 Blood pressure conditions)
		Permethrin 5% dermal cream	(13.2 Infections of the skin)
		Pethidine	(4.5 Pain)
		Phenelzine	(4.2 Mental health disorders)
		Phenindione	(2.3 Blood clots)
		Phenobarbital	(16.6 End of life symptom control- Palliative Care)
		Phenytoin (slow intravenous injection)	(4.6 Seizures)
		Phosphate	(16.2 Gastrointestinal symptoms- Palliative Care)
		Piracetam	(4.3 Movement disorders)
		Piroxicam 0.5% gel	(10.4 Pain and inflammation in musculoskeletal disorders)
		Pivmecillinam hydrochloride (oral)	(5.2 Bacterial infection)
		Pizotifen	(4.5 Pain)
		Potassium chloride syrup (1mmol per mL)	(9.2 Fluid and electrolyte imbalances)
		Potassium hydroxide solution 5% (MolluDab)	(13.2 Infections of the skin)
		Potassium permanganate 400mg (Permitabs)	(13.9 Skin cleansers, antiseptics and desloughing agents)
		Pravastatin	(2.6 Hyperlipidaemia)
		Prednisolone retention enema	(1.1 Chronic bowel disorders)
		Prednisolone suppository	(1.1 Chronic bowel disorders)
		Prednisolone	(16.3 Respiratory symptoms- Palliative Care)
		Pregabalin	(16.1 Pain due to cancer in adults- Palliative Care)
		Pregabalin	(4.5 Pain)
		Primidone	(4.3 Movement disorders)
		Procyclidine	(4.3 Movement disorders)
		Promethazine	(3.2 Allergic conditions)
		Propantheline	(1.6 Gastro-intestinal smooth muscle spasm)
		Propranolol	(2.4 Blood pressure conditions)
		Propranolol	(4.2 Mental health disorders)
		Propranolol	(4.3 Movement disorders)
		Propranolol	(6.9 Thyroid disorders)
		Propylthiouracil	(6.9 Thyroid disorders)
		Prucalopride	(1.2 Constipation and bowel cleansing)
		Pyridoxine	(4.6 Seizures)
		Qtern (Saxagliptin / Dapagliflozin)	(6.3 Diabetes mellitus and hypoglycaemia)
		Qtern (Saxagliptin / Dapagliflozin)	(6.3 Diabetes mellitus and hypoglycaemia)
		Quetiapine	(16.4 Anxiety, depression and confusion- Palliative Care)
		Quetiapine	(4.2 Mental health disorders)
		QV Skin lotion	(13.1 Dry and scaling skin disorders)
		Raloxifene	(6.8 Sex hormone responsive conditions)
		Renavit	(9.6 Vitamin deficiencies)
		Rimegepant	(4.5 Pain)
		Risedronate	(6.4 Disorders of bone metabolism)
		Risperidone	(16.4 Anxiety, depression and confusion- Palliative Care)
		Rivastigmine - includes patches	(4.1 Dementia)
		Rizatriptan	(4.5 Pain)
		Ropinirole	(4.3 Movement disorders)
		Rosuvastatin	(2.6 Hyperlipidaemia)
		Salbutamol (parenteral)	(3.1 Airways disease, obstructive)
		Salbutamol	(16.3 Respiratory symptoms- Palliative Care)
		Saliva replacement gel (Biotene Oralbalance)	(12.3 Oropharynx)
		Salivix pastilles	(12.3 Oropharynx)
		Saxagliptin	(6.3 Diabetes mellitus and hypoglycaemia)
		Semaglutide (oral)	(6.3 Diabetes mellitus and hypoglycaemia)
		Simeticone	(16.3 Respiratory symptoms- Palliative Care)
		Simvastatin	(2.6 Hyperlipidaemia)
		Slynd	(7.3 Contraception)
		Sodium citrate micro-enema	(1.2 Constipation and bowel cleansing)
		Sodium citrate	(1.4 Disorders of gastric acid and ulceration)
		Sodium feredetate elixir (Sytron)	(9.1 Blood and blood–forming organs)
		Sodium fusidate (oral)	(5.2 Bacterial infection)
		Sodium hyaluronate	(11.8 Miscellaneous ophthalmic preparations)
		Spironolactone	(2.5 Heart Failure)
		Sterculia and Frangula (Normacol plus)	(1.2 Constipation and bowel cleansing)
		Sucralfate (oral) (unlicensed)	(1.4 Disorders of gastric acid and ulceration)
		Sucralfate suspension	(16.5 Mouthcare- Palliative Care)
		Sulpiride	(4.2 Mental health disorders)
		Tadalafil tablets (weekly)	(7.4 Erectile and ejaculatory conditions)
		Tafluprost 15microgram/mL preservative free unit dose eye drops	(11.6 Treatment of glaucoma)
		Tafluprost 15micrograms/mL / Timolol 5mg/mL (brands include Taptiqom)	(11.6 Treatment of glaucoma)
		Tamoxifen	(6.8 Sex hormone responsive conditions)
		Telmisartan	(2.4 Blood pressure conditions)
		Terbutaline (inhaled & nebulised)	(3.1 Airways disease, obstructive)
		Terbutaline (unlicensed)	(7.5 Obstetrics)
		Theophylline modified-release (oral)	(3.1 Airways disease, obstructive)
		Timolol 0.1% long acting preservative free eye drops (Tiopex)	(11.6 Treatment of glaucoma)
		Timolol 0.25% long acting eye solution (Timoptol LA)	(11.6 Treatment of glaucoma)
		Timolol 0.5% long acting eye solution (Timoptol LA)	(11.6 Treatment of glaucoma)
		Tiotropium (Spiriva Respimat)	(3.1 Airways disease, obstructive)
		Tirbanibulin ointment	(13.5 Photodamage)
		TLS Blue indications	(9.6 Vitamin deficiencies)
		Tolbutamide	(6.3 Diabetes mellitus and hypoglycaemia)
		Topiramate	(4.5 Pain)
		Tramadol	(16.1 Pain due to cancer in adults- Palliative Care)
		Tramadol	(4.5 Pain)
		Travoprost 40 micrograms / Timolol 5mg/mL eye drops (brands include DuoTrav)	(11.6 Treatment of glaucoma)
		Trazodone	(4.2 Mental health disorders)
		Trifluoperazine	(4.2 Mental health disorders)
		Trihexyphenidyl	(4.3 Movement disorders)
		Trospium modified-release	(7.1 Bladder and urinary disorders)
		Trospium standard-release	(7.1 Bladder and urinary disorders)
		Tuberculin PPD RT 23 SSI, 10 T.U./0.1 mL	(14.3 Tuberculosis diagnostic test)
		UHB solution	(9.2 Fluid and electrolyte imbalances)
		Ultraveen Itch Relief cream	(13.1 Dry and scaling skin disorders)
		Umeclidinium (Incruse Ellipta)	(3.1 Airways disease, obstructive)
		Valaciclovir (oral)	(5.6 Viral infection)
		Verapamil modified-release	(2.4 Blood pressure conditions)
		Vilanterol / Umeclidinium (Anoro Ellipta)	(3.1 Airways disease, obstructive)
		Vita-E capsules	(9.6 Vitamin deficiencies)
		Vitamins B & C high potency (intramuscular) (Pabrinex)	(9.6 Vitamin deficiencies)
		WHO solution / St Marks solution	(9.2 Fluid and electrolyte imbalances)
		Yacella	(7.3 Contraception)
		Zafirlukast	(3.1 Airways disease, obstructive)
		Zuclopenthixol	(4.2 Mental health disorders)

Adult Specialist drugs:

Acarbose tablets	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Acetazolamide	(4.6 Seizures)	Specialist Recommended
Aciclovir 3% eye ointment	(11.3 Anti–infective eye preparations)	Specialist Recommended
Aerobika oscillating positive expiratory pressure device	(3.3 Conditions affecting sputum viscosity)	Specialist Recommended
Alprostadil intracavernosal injection (Caverject, Viridal Duo)	(7.4 Erectile and ejaculatory conditions)	Specialist Recommended
Alprostadil urethral application (Muse)	(7.4 Erectile and ejaculatory conditions)	Specialist Recommended
Alprostadil urethral cream (Vitaros)	(7.4 Erectile and ejaculatory conditions)	Specialist Recommended
Amantadine	(4.3 Movement disorders)	3 month Specialist Initiated
Amiodarone (oral)	(2.1 Arrhythmias)
Anastrozole (oral)	(8.2 Malignant disease)	Specialist Recommended
Apraclonidine 0.5% eye drops	(11.6 Treatment of glaucoma)	Specialist Recommended
Atogepant	(4.5 Pain)	Specialist Initiated
Atomoxetine	(4.2 Mental health disorders)	3 month
Aviptadil / Phentolamine (Invicorp)	(7.4 Erectile and ejaculatory conditions)	Specialist Recommended
Azathioprine (oral & parenteral)	(8.1 Immune system)	3 month
Azathioprine (oral)	(1.7 Liver disorders and related conditions)	3 month
Azathioprine (oral)	(13.3 Inflammatory skin conditions)	3 month
Azathioprine IBD	(1.1 Chronic bowel disorders)	1 month
Azathioprine	(10.1 Arthritis)	1 month
Azathioprine	(11.4 Corticosteroids and other anti–inflammatory preparations)	1 month
Azathioprine	(3.5 Interstitial Lung Disease)	1 month
Betamethasone soluble tablets	(12.3 Oropharynx)	Specialist Recommended
Bicalutamide (oral)	(8.2 Malignant disease)	1 month
Bismuth chelate	(1.4 Disorders of gastric acid and ulceration)	Specialist Recommended
Brivaracetam	(4.6 Seizures)	Specialist Initiated
Bromocriptine	(6.5 Dopamine responsive conditions)	3 month
Budesonide (Budenofalk) (oral)	(1.1 Chronic bowel disorders)	Specialist Recommended
Budesonide MMX (Cortiment) prolonged release tablets	(1.1 Chronic bowel disorders)	Specialist Recommended
Budesonide orodispersible tablets	(1.4 Disorders of gastric acid and ulceration)	3 month
Buserelin nasal spray	(6.6 Gonadotrophin responsive conditions)	Specialist Recommended
Cabergoline	(4.3 Movement disorders)	Specialist Initiated
Cabergoline	(6.5 Dopamine responsive conditions)	3 month
Carbamazepine	(4.2 Mental health disorders)	Specialist Initiated
Carbamazepine	(4.6 Seizures)	Specialist Recommended
Cenobamate	(4.6 Seizures)	Specialist Initiated
Ciclosporin 1mg/mL eye drops (Ikervis)	(11.8 Miscellaneous ophthalmic preparations)	3 month
Cinacalcet	(9.2 Fluid and electrolyte imbalances)	3 month
Clobazam	(4.6 Seizures)	Specialist Recommended
Clonazepam	(4.6 Seizures)	Specialist Recommended
Colesevelam	(1.7 Liver disorders and related conditions)	1 month
Colistimethate sodium (injection to be used via nebuliser)	(3.1 Airways disease, obstructive)	3 month
Colistimethate sodium (injection to be used via nebuliser)	(5.2 Bacterial infection)	3 month
Cyproterone (oral)	(8.2 Malignant disease)
Dalteparin	(2.3 Blood clots)
Danazol	(6.6 Gonadotrophin responsive conditions)	Specialist Initiated
Dapagliflozin	(2.5 Heart Failure)	Specialist Recommended
Dapsone (oral)	(12.3 Oropharynx)	3 month
Dapsone (oral)	(13.3 Inflammatory skin conditions)	3 month
Degarelix (Firmagon) (subcutaneous)	(8.2 Malignant disease)	1 month
Denosumab	(6.4 Disorders of bone metabolism)	3 month
Dequalinium chloride (Fluomizin 10mg vaginal tablets)	(7.6 Vaginal and vulval conditions)	Specialist Recommended
Desmopressin (Noqdirna)	(7.1 Bladder and urinary disorders)	3 month
Dexamethasone soluble tablets (oral rinse)	(12.3 Oropharynx)	Specialist Recommended
Dexamfetamine	(4.2 Mental health disorders)	3 month
Dexamfetamine	(4.7 Sleep disorders)	3 month
Dienogest tablets	(6.8 Sex hormone responsive conditions)	Specialist Recommended
Doxepin 5% cream	(4.5 Pain)	Specialist Recommended
Dronedarone	(2.1 Arrhythmias)	3 month
Duloxetine	(7.1 Bladder and urinary disorders)	Specialist Recommended
Empagliflozin	(2.5 Heart Failure)	Specialist Recommended
Enoxaparin	(2.3 Blood clots)
Entacapone	(4.3 Movement disorders)	Specialist Recommended
Eplerenone	(2.5 Heart Failure)	Specialist Recommended
Ertapenem (parenteral)	(5.2 Bacterial infection)	Specialist Recommended
Eslicarbazepine	(4.6 Seizures)	Specialist Initiated
Ethosuximide	(4.6 Seizures)	Specialist Recommended
Fiasp	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Fidaxomicin (oral)	(5.2 Bacterial infection)	Specialist Recommended
Finerenone	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Flecainide (oral)	(2.1 Arrhythmias)	Specialist Recommended
Fluocinolone Acetonide 0.025% gel (Synalar) (oral)	(12.3 Oropharynx)	Specialist Recommended
Flupentixol decanoate	(4.2 Mental health disorders)	1 month
Fluphenazine decanoate	(4.2 Mental health disorders)	1 month
Fosfomycin (oral & parenteral)	(5.2 Bacterial infection)	Specialist Recommended
Gabapentin	(4.6 Seizures)	Specialist Recommended
Ganciclovir 0.15% eye gel	(11.3 Anti–infective eye preparations)	Specialist Recommended
Gentamicin (nebulised)	(5.2 Bacterial infection)	3 month
Glycopyrronium bromide	(12.3 Oropharynx)	3 month
Goserelin (Zoladex)	(6.6 Gonadotrophin responsive conditions)
Guanfacine modified release tablets	(4.2 Mental health disorders)	3 month
Haloperidol decanoate	(4.2 Mental health disorders)	1 month
Humalog Mix 25	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Humalog Mix 50	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Hydrocortisone (Efmody)	(6.2 Corticosteroid responsive conditions)	Specialist Recommended
Hydroxycarbamide (oral - capsules)	(8.2 Malignant disease)	3 month
Hydroxychloroquine (oral)	(13.3 Inflammatory skin conditions)	1 month
Hydroxychloroquine	(10.1 Arthritis)	1 month
Hypertonic Sodium chloride 3% or 6% or 7%	(3.3 Conditions affecting sputum viscosity)	Specialist Initiated
Ibandronic acid 50mg tablet	(6.4 Disorders of bone metabolism)	3 month
Ivabradine	(2.7 Myocardial ischaemia)	3 month
Ketorolac subcutaneous injection	(16.1 Pain due to cancer in adults- Palliative Care)	Specialist Recommended
Lacosamide	(4.5 Pain)	3 month
Lacosamide	(4.6 Seizures)	3 month
Lamotrigine	(4.2 Mental health disorders)	Specialist Recommended
Lamotrigine	(4.6 Seizures)	Specialist Recommended
Lanthanum	(9.2 Fluid and electrolyte imbalances)	Specialist Recommended
Lecicarbon A suppositories	(1.2 Constipation and bowel cleansing)	Specialist Recommended
Leflunomide	(10.1 Arthritis)	1 month
Leuprorelin (e.g. Staladex, Prostap)	(6.6 Gonadotrophin responsive conditions)	Specialist Recommended
Leuprorelin (Prostap)	(6.6 Gonadotrophin responsive conditions)	3 month Specialist Recommended
Levetiracetam (parenteral)	(4.6 Seizures)	Specialist Recommended
Levetiracetam	(4.6 Seizures)	Specialist Recommended
Levodopa / Carbidopa / Entacapone	(4.3 Movement disorders)	Specialist Recommended
Lidocaine patch	(4.5 Pain)	Specialist Recommended
Lidocaine patches	(16.1 Pain due to cancer in adults- Palliative Care)	Specialist Recommended
Linaclotide	(1.1 Chronic bowel disorders)	Specialist Recommended
Lisdexamfetamine	(4.2 Mental health disorders)	3 month
Lithium carbonate modified-release	(4.2 Mental health disorders)	3 month
Lithium citrate liquid	(4.2 Mental health disorders)	3 month
Loteprednol 0.5% eye drops	(11.4 Corticosteroids and other anti–inflammatory preparations)	Specialist Recommended
Lyumjev	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Melatonin modified-release and immediate-release	(4.7 Sleep disorders)	3 month
Mercaptopurine (oral)	(1.7 Liver disorders and related conditions)	3 month
Mercaptopurine (oral)	(8.1 Immune system)	3 month
Mercaptopurine IBD	(1.1 Chronic bowel disorders)	1 month
Methotrexate (oral & subcutaneous)	(13.3 Inflammatory skin conditions)	3 month
Methotrexate (oral) 2.5mg tablets only - weekly dose	(10.1 Arthritis)	1 month
Methotrexate (oral)	(8.2 Malignant disease)
Methotrexate (parenteral) - weekly dose	(10.1 Arthritis)	1 month
Methotrexate	(4.3 Movement disorders)	3 month
Methotrexate IBD	(1.1 Chronic bowel disorders)	1 month
Methotrexate	(11.4 Corticosteroids and other anti–inflammatory preparations)	1 month
Methotrexate	(3.5 Interstitial Lung Disease)	1 month
Methylphenidate modified-release and immediate-release	(4.2 Mental health disorders)	3 month
Midodrine	(2.4 Blood pressure conditions)	Specialist Initiated
Minocycline (oral)	(5.2 Bacterial infection)	Specialist Recommended
Modafinil	(4.7 Sleep disorders)	3 month
Mycophenolate (oral)	(13.3 Inflammatory skin conditions)	3 month
Mycophenolate (oral)	(10.1 Arthritis)	3 month
Mycophenolate mofetil (oral)	(1.7 Liver disorders and related conditions)	3 month
Mycophenolate mofetil / Mycophenolic acid (oral)	(8.1 Immune system)	3 month
Mycophenolate	(1.1 Chronic bowel disorders)	3 month
Mycophenolate	(10.3 Neuromuscular disorders)	3 month
Mycophenolate	(11.4 Corticosteroids and other anti–inflammatory preparations)	3 month
Mycophenolate	(3.5 Interstitial Lung Disease)	3 month
n® o	(6.4 Disorders of bone metabolism)	Specialist Initiated
Nalmefene	(4.8 Substance dependence)	Specialist Recommended
Naltrexone	(4.8 Substance dependence)	1 month
Novomix 30	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Opicapone	(4.3 Movement disorders)	3 month
Ospemifene tablets	(7.6 Vaginal and vulval conditions)	Specialist Recommended
Oxcarbazepine	(4.6 Seizures)	3 month
Patiromer	(9.2 Fluid and electrolyte imbalances)	Specialist Initiated
Penicillamine	(10.1 Arthritis)	1 month
Penicillamine	(9.3 Metabolic disorders)	3 month
Perampanel	(4.6 Seizures)	Specialist Initiated
Phenobarbital	(4.6 Seizures)	Specialist Recommended
Phenytoin	(4.6 Seizures)	Specialist Recommended
Pilocarpine tablets	(12.3 Oropharynx)	Specialist Recommended
Potassium Chloride 600mg (8mmol) modified release tablets	(9.2 Fluid and electrolyte imbalances)	Specialist Recommended
Pramipexole (including modified-release)	(4.3 Movement disorders)	Specialist Initiated
Prasugrel	(2.7 Myocardial ischaemia)	1 month
Pregabalin	(4.6 Seizures)	Specialist Initiated
Primidone	(4.6 Seizures)	Specialist Recommended
Propafenone (oral)	(2.1 Arrhythmias)	Specialist Recommended
Pyridoxine hydrochloride / doxylamine succinate (Xonvea) tablets	(4.4 Nausea and labyrinth disorders)	Specialist Initiated
Qlaira (estradiol valerate / dienogest)	(7.3 Contraception)	Specialist Recommended
Ranolazine	(2.7 Myocardial ischaemia)	1 month
Rasagiline	(4.3 Movement disorders)	Specialist Initiated
Relugolix-estradiol-norethisterone acetate (Ryeqo	(7.3 Contraception)	Specialist Initiated
Rifampicin (oral)	(5.2 Bacterial infection)	Specialist Recommended
Rifaximin (oral)	(5.2 Bacterial infection)	Specialist Initiated
Riluzole	(4.3 Movement disorders)	3 month
Rimegepant	(4.5 Pain)	Specialist Initiated
Rivaroxaban	(2.3 Blood clots)	1 month 3 month
Roflumilast	(3.1 Airways disease, obstructive)	Specialist Initiated
Ropinirole (including modified-release & starter pack)	(4.3 Movement disorders)	Specialist Initiated
Rotigotine	(4.3 Movement disorders)	Specialist Recommended
Rufinamide	(4.6 Seizures)	Specialist Initiated
Sacubitril / Valsartan (Entresto)	(2.5 Heart Failure)	1 month
Safinamide	(4.3 Movement disorders)	3 month
Selegiline	(4.3 Movement disorders)	Specialist Initiated
Sevelamer	(9.2 Fluid and electrolyte imbalances)	Specialist Recommended
Sildenafil	(10.1 Arthritis)	3 month
Silicone Gel	(13.13 Miscellaneous skin preparations)	Specialist Recommended
Sodium valproate / Valproic acid (Depakote)	(4.2 Mental health disorders)	3 month
Sodium valproate	(4.5 Pain)	3 month
Sodium zirconium cyclosilicate	(9.2 Fluid and electrolyte imbalances)	Specialist Initiated
Spironolactone (oral)	(13.7 Rosacea and acne)	Specialist Initiated
Spironolactone (oral)	(13.3 Inflammatory skin conditions)	Specialist Initiated
Sucralfate 2g/50mL enema	(1.4 Disorders of gastric acid and ulceration)	Specialist Recommended
Sucroferric oxyhydroxide	(9.2 Fluid and electrolyte imbalances)	Specialist Recommended
Sulfasalazine	(1.1 Chronic bowel disorders)	1 month
Sulfasalazine	(10.1 Arthritis)	1 month
Tadalafil 5mg tablets (once daily)	(7.4 Erectile and ejaculatory conditions)	Specialist Initiated
Tamoxifen (oral)	(8.2 Malignant disease)	Specialist Recommended
Tapentadol modified-release	(4.5 Pain)	3 month
Testosterone gel (Tostran 2% gel / Testogel 40.5mg/2.5g gel sachets)	(6.8 Sex hormone responsive conditions)	3 month
Testosterone oily injection (Nebido® and Sustanon 250)	(6.8 Sex hormone responsive conditions)	3 month
Tetrabenazine	(4.3 Movement disorders)	Specialist Initiated
Tiagabine	(4.6 Seizures)	Specialist Recommended
Ticagrelor	(2.7 Myocardial ischaemia)	1 month
Tinzaparin	(2.3 Blood clots)
Tiotropium (Respimat)	(3.1 Airways disease, obstructive)	Specialist Recommended
Tobramycin (nebulised)	(3.1 Airways disease, obstructive)	3 month
Tobramycin (nebulised)	(5.2 Bacterial infection)	3 month
Topiramate	(4.6 Seizures)	Specialist Recommended
Toujeo Solostar U300	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Toujeo	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Tresiba U100	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Tresiba U200	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Tresiba	(6.3 Diabetes mellitus and hypoglycaemia)	Specialist Recommended
Triptorelin (Decapeptyl SR)	(6.6 Gonadotrophin responsive conditions)	Specialist Recommended
Vardenafil	(7.4 Erectile and ejaculatory conditions)	Specialist Recommended
Verapamil (immediate release tablets)	(4.5 Pain)	3 month
VisuXL Gel	(11.8 Miscellaneous ophthalmic preparations)	Specialist Recommended
Vitamin A+D	(9.6 Vitamin deficiencies)	Specialist Recommended
Vortioxetine	(4.2 Mental health disorders)	Specialist Recommended
Zonisamide	(4.6 Seizures)	Specialist Initiated
Zuclopenthixol decanoate	(4.2 Mental health disorders)	1 month

Adult Secondary care drugs:

		5-aminolaevulinic acid gel (Ameluz)	(13.5 Photodamage)
		Abacavir (oral)	(5.6 Viral infection)
		Abacavir / Dolutegravir / Lamivudine (oral) (Triumeq)	(5.6 Viral infection)
		Abatacept	(10.1 Arthritis)
		Abemaciclib (oral)	(8.2 Malignant disease)
		Abiraterone (oral)	(8.2 Malignant disease)
		Abrocitinib (oral)	(13.3 Inflammatory skin conditions)
		Acalabrutinib (oral)	(8.2 Malignant disease)
		Acarizax (oral)	(3.2 Allergic conditions)
		Acetic acid solution	(1.4 Disorders of gastric acid and ulceration)
		Acetylcholine	(2.7 Myocardial ischaemia)
		Acetylcysteine (unlicensed)	(3.3 Conditions affecting sputum viscosity)
		Acetylcysteine 10% eye drops (unlicensed)	(11.8 Miscellaneous ophthalmic preparations)
		Aciclovir (parenteral)	(5.6 Viral infection)
		Acid citrate dextrose	(17.1 Miscellaneous Preparations)
		Acitretin	(13.3 Inflammatory skin conditions)
		Actilyse Cathflo	(2.7 Myocardial ischaemia)
		Adalimumab (parenteral)	(13.3 Inflammatory skin conditions)
		Adalimumab	(1.1 Chronic bowel disorders)
		Adalimumab	(10.1 Arthritis)
		Adalimumab	(11.8 Miscellaneous ophthalmic preparations)
		Addaven	(9.4 Trace element deficiencies)
		Adefovir dipivoxil (oral)	(5.6 Viral infection)
		Adenosine	(2.1 Arrhythmias)
		Adrenaline (epinephrine) 1 in 10,000 (100micrograms/mL)	(2.4 Blood pressure conditions)
		Afatinib (oral)	(8.2 Malignant disease)
		Aflibercept	(11.8 Miscellaneous ophthalmic preparations)
		Ajmaline	(2.1 Arrhythmias)
		Albendazole (oral) (unlicensed)	(5.4 Helminth infection)
		Aldesleukin (parenteral)	(8.2 Malignant disease)
		Alectinib (oral)	(8.2 Malignant disease)
		Alemtuzumab (parenteral)	(8.1 Immune system)
		Alfacalcidol (parenteral)	(9.6 Vitamin deficiencies)
		Alfentanil injection	(4.5 Pain)
		Alfentanil intranasal	(4.5 Pain)
		Alfentanil	(15.1 General Anaesthesia)
		Alirocumab	(2.6 Hyperlipidaemia)
		Aliskiren	(2.4 Blood pressure conditions)
		Alitretinoin	(13.3 Inflammatory skin conditions)
		All intravenous nutrition	(9.5 Nutrition)
		Alpelisib (oral)	(8.2 Malignant disease)
		Alteplase (For all indications except acute MI)	(2.7 Myocardial ischaemia)
		Alteplase	(2.3 Blood clots)
		Aluminium acetate 13% drops	(12.1 Ear)
		Alutard	(3.2 Allergic conditions)
		Ambrisentan (oral)	(2.4 Blood pressure conditions)
		Amikacin (intravesical)	(5.2 Bacterial infection)
		Amikacin (nebulised)	(5.2 Bacterial infection)
		Amikacin (parenteral)	(5.2 Bacterial infection)
		Amikacin 35mg/mL (unlicensed)	(11.3 Anti–infective eye preparations)
		Aminophylline (parenteral)	(3.1 Airways disease, obstructive)
		Amiodarone (intravenous)	(2.1 Arrhythmias)
		Amphotericin 0.15% eye drops (unlicensed)	(11.3 Anti–infective eye preparations)
		Amsacrine (parenteral)	(8.2 Malignant disease)
		Anagrelide	(9.1 Blood and blood–forming organs)
		Anakinra	(10.1 Arthritis)
		Anakinra	(8.1 Immune system)
		Andexanet Alfa	(2.3 Blood clots)
		Anidulafungin (parenteral)	(5.3 Fungal infection)
		Anti-D (Rho) immunoglobulin	(14.1 Immunoglobulin therapy)
		Antithymocyte globulin (ATG) (horse)	(8.1 Immune system)
		Antithymocyte globulin (ATG) (rabbit)	(8.1 Immune system)
		Apalutamide	(8.2 Malignant disease)
		Apixaban	(2.3 Blood clots)
		Apomorphine	(4.3 Movement disorders)
		Apremilast	(10.1 Arthritis)
		Apremilast	(13.3 Inflammatory skin conditions)
		Aprepitant	(4.4 Nausea and labyrinth disorders)
		Aqueous Iodine Oral Solution (Lugol's Solution)	(6.9 Thyroid disorders)
		Argatroban	(2.3 Blood clots)
		Arsenic trioxide (parenteral)	(8.2 Malignant disease)
		Artemether / Lumefantrine (oral) (Riamet)	(5.5 Protozoal infection)
		Artesunate (parenteral) (unlicensed)	(5.5 Protozoal infection)
		Asciminib (oral)	(8.2 Malignant disease)
		Atazanavir (oral)	(5.6 Viral infection)
		Atazanavir / Cobicistat (Evotaz)	(5.6 Viral infection)
		Atezolizumab (parenteral)	(8.2 Malignant disease)
		Atosiban	(7.5 Obstetrics)
		Atovaquone (oral)	(5.3 Fungal infection)
		Atracurium	(15.1 General Anaesthesia)
		Autologous anti-CD19-transduced CD3+ cells	(8.2 Malignant disease)
		Autologous chondrocyte implantation	(17.1 Miscellaneous Preparations)
		Avacopan	(2.9 Vascular disease)
		Avatrombopag	(9.1 Blood and blood–forming organs)
		Avelumab (parenteral)	(8.2 Malignant disease)
		Axicabtagene ciloleucel	(8.2 Malignant disease)
		Axitinib (oral)	(8.2 Malignant disease)
		Azacitidine	(8.2 Malignant disease)
		Azathioprine (oral & parenteral)	(8.1 Immune system)
		Azithromycin 1.5% eye drops	(11.3 Anti–infective eye preparations)
		Aztreonam (nebulised)	(5.2 Bacterial infection)
		Baclofen (intrathecal)	(10.3 Neuromuscular disorders)
		Baricitinib	(10.1 Arthritis)
		Baricitinib	(13.3 Inflammatory skin conditions)
		Baricitinib	(5.7 Treatment of COVID-19)
		Basiliximab (parenteral)	(8.1 Immune system)
		BCG bladder irrigation (instillation)	(8.2 Malignant disease)
		Bedaquiline (oral)	(5.2 Bacterial infection)
		Belimumab	(10.1 Arthritis)
		Belimumab	(8.1 Immune system)
		Belumosudil	(8.1 Immune system)
		Belzutifan	(8.2 Malignant disease)
		Bendamustine (parenteral)	(8.2 Malignant disease)
		Benralizumab	(3.1 Airways disease, obstructive)
		Benzathine benzylpenicillin (parenteral) (unlicensed)	(5.2 Bacterial infection)
		Beriplex P/N (dried prothrombin complex)	(2.2 Bleeding disorders)
		Berotralstat	(3.2 Allergic conditions)
		Betaine	(9.3 Metabolic disorders)
		Bevacizumab (intravitreal)	(8.2 Malignant disease)
		Bevacizumab (parenteral)	(8.2 Malignant disease)
		Bevacizumab	(11.8 Miscellaneous ophthalmic preparations)
		Bexarotene (oral)	(8.2 Malignant disease)
		Bictegravir / Emtricitabine / Tenofovir Alafenamide (oral) (Biktarvy)	(5.6 Viral infection)
		Bimekizumab	(10.1 Arthritis)
		Bimekizumab	(13.3 Inflammatory skin conditions)
		Bismuth subnitrate and Iodoform (BIPP) paste	(12.2 Nose)
		Bivalirudin	(2.3 Blood clots)
		Bleomycin (IV) electrochemotherapy treatment	(8.2 Malignant disease)
		Bleomycin (parenteral)	(8.2 Malignant disease)
		Bleomycin	(2.9 Vascular disease)
		Blinatumomab	(8.2 Malignant disease)
		Bone morphogenetic protein (Inductos, Osigraft)	(17.1 Miscellaneous Preparations)
		Bortezomib (parenteral)	(8.2 Malignant disease)
		Bosentan (oral)	(2.4 Blood pressure conditions)
		Bosutinib (parenteral)	(8.2 Malignant disease)
		Botulinum toxin type A (Botox, Dysport, Xeomin)	(4.3 Movement disorders)
		Botulinum toxin type A	(11.8 Miscellaneous ophthalmic preparations)
		Botulinum toxin type A	(4.5 Pain)
		Botulinum toxin type A	(1.6 Gastro-intestinal smooth muscle spasm)
		Botulinum toxin type A	(1.9 Rectal and anal disorders)
		Botulinum toxin type A	(12.3 Oropharynx)
		Botulinum toxin type A	(4.5 Pain)
		Botulinum toxin type A	(7.1 Bladder and urinary disorders)
		Botulinum toxin type B (Neurobloc)	(4.3 Movement disorders)
		Botulism antitoxin	(14.2 Post-exposure prophylaxis)
		Brentuximab (parenteral)	(8.2 Malignant disease)
		Brexucabtagene autoleucel	(8.2 Malignant disease)
		Brigatinib (oral)	(8.2 Malignant disease)
		Brodalumab	(13.3 Inflammatory skin conditions)
		Brolucizumab	(11.8 Miscellaneous ophthalmic preparations)
		Budesonide (Targeted-release)	(6.2 Corticosteroid responsive conditions)
		Budesonide orodispersible tablets	(1.4 Disorders of gastric acid and ulceration)
		Bulevirtide	(5.6 Viral infection)
		Bupivacaine 0.1% / Fentanyl 2micrograms/mL	(15.2 Local anaesthesia)
		Bupivacaine 0.1% for epidural infusion	(15.2 Local anaesthesia)
		Bupivacaine 0.25% / Adrenaline 1 in 200,000 injection	(15.2 Local anaesthesia)
		Bupivacaine 0.25% & 0.5% injection	(15.2 Local anaesthesia)
		Bupivacaine 0.5% / Adrenaline 1 in 200,000 injection	(15.2 Local anaesthesia)
		Bupivacaine 5mg / Glucose 80mg/mL injection	(15.2 Local anaesthesia)
		Buserelin nasal spray	(6.6 Gonadotrophin responsive conditions)
		Busulfan (Busulphan) (oral & parenteral)	(8.2 Malignant disease)
		C1-esterase inhibitor (Berinert, Cinryze)	(3.2 Allergic conditions)
		Cabazitaxel (parenteral)	(8.2 Malignant disease)
		Cabotegravir with Rilpivirine	(5.6 Viral infection)
		Cabozantinib (oral)	(8.2 Malignant disease)
		Cacicol	(11.8 Miscellaneous ophthalmic preparations)
		Calcitonin salmon (salcatonin) injection	(6.4 Disorders of bone metabolism)
		Calcitriol (parenteral)	(9.6 Vitamin deficiencies)
		Canakinumab	(8.1 Immune system)
		Cangrelor	(2.7 Myocardial ischaemia)
		Cannabidiol (Epidyolex)	(4.6 Seizures)
		Capecitabine (oral)	(8.2 Malignant disease)
		Caphosol mouthwash	(12.3 Oropharynx)
		Caplacizumab (parenteral)	(8.2 Malignant disease)
		Capsaicin patch (Qutenza)	(4.5 Pain)
		Carbetocin	(7.5 Obstetrics)
		Carboplatin (parenteral)	(8.2 Malignant disease)
		Carboprost	(7.5 Obstetrics)
		Carfilzomib	(8.2 Malignant disease)
		Carmustine implant (parenteral) (Glidael)	(8.2 Malignant disease)
		Carnitine	(9.3 Metabolic disorders)
		Casirivimab and Imdevimab	(5.7 Treatment of COVID-19)
		Caspofungin (parenteral)	(5.3 Fungal infection)
		Cefazolin (parenteral)	(5.2 Bacterial infection)
		Cefiderocol (parenteral)	(5.2 Bacterial infection)
		Cefoxitin (parenteral) (unlicensed)	(5.2 Bacterial infection)
		Ceftazidime (parenteral)	(5.2 Bacterial infection)
		Ceftazidime / Avibactam (parenteral)	(5.2 Bacterial infection)
		Ceftolozane & Tazobactam (parenteral)	(5.2 Bacterial infection)
		Cefuroxime (parenteral)	(5.2 Bacterial infection)
		Cefuroxime 5% eye drops (unlicensed)	(11.3 Anti–infective eye preparations)
		Cefuroxime injection (Aprokam)	(11.3 Anti–infective eye preparations)
		Cemiplimab (parenteral)	(8.2 Malignant disease)
		Ceritinib (oral)	(8.2 Malignant disease)
		Cernevit	(9.6 Vitamin deficiencies)
		Certolizumab pegol (parenteral)	(13.3 Inflammatory skin conditions)
		Certolizumab pegol	(10.1 Arthritis)
		Cetuximab (parenteral)	(8.2 Malignant disease)
		Chenodeoxycholic Acid	(1.7 Liver disorders and related conditions)
		Chlorambucil (oral)	(8.2 Malignant disease)
		Chloramphenicol (oral & parenteral)	(5.2 Bacterial infection)
		Chlorhexidine 0.02% eye drops (unlicensed)	(11.3 Anti–infective eye preparations)
		Chlorhexidine 0.2% eye drops (unlicensed)	(11.3 Anti–infective eye preparations)
		Chlormethine gel	(8.2 Malignant disease)
		Chloroprocaine solution	(15.2 Local anaesthesia)
		Chloroquine (oral)	(5.5 Protozoal infection)
		Cholic Acid	(1.7 Liver disorders and related conditions)
		Chorionic gonadotropin	(6.7 Hypothalamic and anterior pituitary hormone related disorders)
		Ciclosporin (oral & parenteral)	(8.1 Immune system)
		Ciclosporin (oral)	(13.3 Inflammatory skin conditions)
		Ciclosporin 0.2% eye ointment (unlicensed)	(11.8 Miscellaneous ophthalmic preparations)
		Ciclosporin	(1.1 Chronic bowel disorders)
		Ciclosporin	(10.1 Arthritis)
		Cidofovir (parenteral)	(5.6 Viral infection)
		Cinacalcet	(9.2 Fluid and electrolyte imbalances)
		Ciprofloxacin (parenteral)	(5.2 Bacterial infection)
		Cisatracurium	(15.1 General Anaesthesia)
		Cisplatin (parenteral)	(8.2 Malignant disease)
		Cladribine (oral)	(8.1 Immune system)
		Cladribine (parenteral)	(8.2 Malignant disease)
		Clarithromycin (parenteral)	(5.2 Bacterial infection)
		Clindamycin (oral & parenteral)	(5.3 Fungal infection)
		Clindamycin (parenteral)	(5.2 Bacterial infection)
		Clofarabine (parenteral)	(8.2 Malignant disease)
		Clofazimine (oral) (unlicensed)	(5.2 Bacterial infection)
		Clonazepam (parenteral)	(4.6 Seizures)
		Clonidine	(15.1 General Anaesthesia)
		Clozapine	(4.2 Mental health disorders)
		CMV immunoglobulin	(14.1 Immunoglobulin therapy)
		Co-amoxiclav (parenteral)	(5.2 Bacterial infection)
		Co-careldopa + levodopa intestinal gel (Duodopa)	(4.3 Movement disorders)
		Co-trimoxazole (parenteral)	(5.2 Bacterial infection)
		Co-trimoxazole (parenteral)	(5.3 Fungal infection)
		Cobicistat / Darunavir / Emtricitabine / Tenofovir (oral) (Symtuza)	(5.6 Viral infection)
		Cocaine 10% solution	(15.2 Local anaesthesia)
		Cocaine 5% / Adrenaline 1:2000 gel	(15.2 Local anaesthesia)
		Cocaine 5% solution	(15.2 Local anaesthesia)
		Colistimethate sodium (injection to be used via nebuliser)	(3.1 Airways disease, obstructive)
		Colistimethate sodium (injection to be used via nebuliser)	(5.2 Bacterial infection)
		Colistimethate sodium (parenteral)	(5.2 Bacterial infection)
		Colistimethate sodium Dry Powder Inhaler (inhaled)	(3.1 Airways disease, obstructive)
		Colistimethate sodium Dry Powder Inhaler (inhaled)	(5.2 Bacterial infection)
		Colobreathe 1,662,500unit inhalation powder capsules (inhaled)	(3.1 Airways disease, obstructive)
		Conestat alfa (Ruconest)	(3.2 Allergic conditions)
		Crisantaspase (parenteral)	(8.2 Malignant disease)
		Crizotinib (oral)	(8.2 Malignant disease)
		Cyclophosphamide (oral & parenteral)	(8.2 Malignant disease)
		Cyclophosphamide	(10.1 Arthritis)
		Cycloserine (oral)	(5.2 Bacterial infection)
		Cyproterone	(6.8 Sex hormone responsive conditions)
		Cytarabine (parenteral)	(8.2 Malignant disease)
		Dabigatran	(2.3 Blood clots)
		Dabrafenib (parenteral)	(8.2 Malignant disease)
		Dacarbazine (parenteral)	(8.2 Malignant disease)
		Dacomitinib (oral)	(8.2 Malignant disease)
		Dactinomycin (parenteral)	(8.2 Malignant disease)
		Dalbavancin (parenteral)	(5.2 Bacterial infection)
		Danaparoid	(2.3 Blood clots)
		Dantrolene	(15.1 General Anaesthesia)
		Dapsone (oral)	(5.2 Bacterial infection)
		Dapsone (oral)	(5.3 Fungal infection)
		Daptomycin (parenteral)	(5.2 Bacterial infection)
		Daratumumab (parenteral)	(8.2 Malignant disease)
		Darbepoetin alfa	(9.1 Blood and blood–forming organs)
		Darolutamide (oral)	(8.2 Malignant disease)
		Darunavir (oral)	(5.6 Viral infection)
		Darunavir / Cobicistat (Rezolsta)	(5.6 Viral infection)
		Dasatinib (oral)	(8.2 Malignant disease)
		Daunorubicin (parenteral)	(8.2 Malignant disease)
		Deferasirox	(9.1 Blood and blood–forming organs)
		Deferiprone	(9.1 Blood and blood–forming organs)
		Defibrotide	(2.3 Blood clots)
		Delamanid (oral)	(5.2 Bacterial infection)
		Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) (Sativex) oromucosal spray	(10.3 Neuromuscular disorders)
		Denosumab	(6.4 Disorders of bone metabolism)
		Dequalinium chloride (Fluomizin 10mg vaginal tablets)	(7.6 Vaginal and vulval conditions)
		Dermovate with 40% Propylene glycol	(13.3 Inflammatory skin conditions)
		Desferrioxamine	(9.1 Blood and blood–forming organs)
		Desferrioxamine	(9.1 Blood and blood–forming organs)
		Deucravacitinib	(13.3 Inflammatory skin conditions)
		Dexamethasone intravitreal implant 700micrograms (Ozurdex)	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Dexmedetomidine	(15.1 General Anaesthesia)
		Diazepam (parenteral)	(4.6 Seizures)
		Diazepam rectal tubes	(4.6 Seizures)
		Diazoxide	(2.4 Blood pressure conditions)
		Dibotermin alfa	(10.5 Soft tissue and joint disorders)
		Diclofenac 0.1% preservative free eye drops	(11.8 Miscellaneous ophthalmic preparations)
		Didanosine (oral)	(5.6 Viral infection)
		Difelikefalin	(13.6 Pruritis)
		Digoxin (intravenous)	(2.1 Arrhythmias)
		Digoxin-specific antibody fragments	(2.1 Arrhythmias)
		Dimethyl fumarate (oral)	(13.3 Inflammatory skin conditions)
		Dimethyl fumarate (oral)	(8.1 Immune system)
		Dinoprostone pessaries (Propess)	(7.5 Obstetrics)
		Dinoprostone vaginal tablet & vaginal gel (Prostin E2)	(7.5 Obstetrics)
		Dinutuximab beta (parenteral)	(8.2 Malignant disease)
		Dipotassium hydrogen phosphate	(9.2 Fluid and electrolyte imbalances)
		Diroximel fumarate (oral)	(8.1 Immune system)
		Disodium pamidronate	(6.4 Disorders of bone metabolism)
		Dithranol in Lassar’s paste 0.1 to 2%	(13.3 Inflammatory skin conditions)
		Dobutamine	(2.7 Myocardial ischaemia)
		Docetaxel (parenteral)	(8.2 Malignant disease)
		Dolutegravir (oral)	(5.6 Viral infection)
		Dolutegravir / Lamivudine (oral) (Dovato)	(5.6 Viral infection)
		Dolutegravir / Rilpivirine (oral) (Juluca)	(5.6 Viral infection)
		Doravirine (oral)	(5.6 Viral infection)
		Doravirine / Lamivudine / Tenofovir disoproxil fumarate (oral) (Delstrigo)	(5.6 Viral infection)
		Dornase alfa	(3.3 Conditions affecting sputum viscosity)
		Dostarlimab	(8.2 Malignant disease)
		Doxapram	(3.6 Respiratory depression, respiratory distress syndrome and apnoea)
		Doxepin hydrochloride 5% cream	(13.6 Pruritis)
		Doxorubicin (parenteral)	(8.2 Malignant disease)
		Doxorubicin, pegylated liposomal (parenteral)	(8.2 Malignant disease)
		Droperidol	(4.2 Mental health disorders)
		Droperidol	(4.4 Nausea and labyrinth disorders)
		Dupilumab (parenteral)	(13.3 Inflammatory skin conditions)
		Dupilumab	(3.1 Airways disease, obstructive)
		Durvalumab (parenteral)	(8.2 Malignant disease)
		Eculizumab	(9.1 Blood and blood–forming organs)
		Efavirenz (oral)	(5.6 Viral infection)
		Elbasvir / Grazoprevir (oral) (Zepatier)	(5.6 Viral infection)
		Eleview lifting solution	(17.1 Miscellaneous Preparations)
		Elexacaftor / Tezacaftor / Ivacaftor	(3.3 Conditions affecting sputum viscosity)
		Elranatamab	(8.2 Malignant disease)
		Eltrombopag	(9.1 Blood and blood–forming organs)
		Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide (oral) (Genvoya)	(5.6 Viral infection)
		Emicizumab	(2.3 Blood clots)
		Emtricitabine (oral)	(5.6 Viral infection)
		Emtricitabine / Tenofovir Alafenamide (oral) (Descovy)	(5.6 Viral infection)
		Emtricitabine / Tenofovir disoproxil	(5.6 Viral infection)
		Encorafenib (oral)	(8.2 Malignant disease)
		Enfuvirtide (parenteral)	(5.6 Viral infection)
		Enoximone	(2.5 Heart Failure)
		Entecavir (oral)	(5.6 Viral infection)
		Entrectinib	(8.2 Malignant disease)
		Enzalutamide (oral)	(8.2 Malignant disease)
		Epcoritamab	(8.2 Malignant disease)
		Ephedrine hydrochloride tablets	(2.4 Blood pressure conditions)
		Ephedrine	(2.4 Blood pressure conditions)
		Epirubicin (parenteral)	(8.2 Malignant disease)
		Epoprostenol (intravenous)	(2.4 Blood pressure conditions)
		Epoprostenol	(2.3 Blood clots)
		Eptifibatide (Integrellin)	(2.3 Blood clots)
		Eptinezumab	(4.5 Pain)
		Erenumab	(4.5 Pain)
		Ergocalciferol (parenteral)	(9.6 Vitamin deficiencies)
		Ergometrine	(7.5 Obstetrics)
		Eribulin (parenteral)	(8.2 Malignant disease)
		Erlotinib (oral)	(8.2 Malignant disease)
		Erythromycin (parenteral)	(5.2 Bacterial infection)
		Erythromycin 0.5% eye ointment (unlicensed)	(11.3 Anti–infective eye preparations)
		Erythropoietin (Epoetin) beta	(9.1 Blood and blood–forming organs)
		Esmolol (intravenous)	(2.4 Blood pressure conditions)
		Etanercept (parenteral)	(13.3 Inflammatory skin conditions)
		Etanercept	(10.1 Arthritis)
		Etelcalcetide	(9.2 Fluid and electrolyte imbalances)
		Ethambutol hydrochloride (oral)	(5.2 Bacterial infection)
		Ethanolamine oleate	(2.9 Vascular disease)
		Etomidate	(15.1 General Anaesthesia)
		Etoposide (oral & parenteral)	(8.2 Malignant disease)
		Etoposide phosphate (parenteral)	(8.2 Malignant disease)
		Etranacogene dezaparvovec	(2.2 Bleeding disorders)
		Etrasimod	(1.1 Chronic bowel disorders)
		Etravirine (oral)	(5.6 Viral infection)
		Everolimus (oral)	(8.2 Malignant disease)
		Evolocumab	(2.6 Hyperlipidaemia)
		Exagamglogene autotemcel	(9.1 Blood and blood–forming organs)
		Faecal Microbiota Transplant	(5.2 Bacterial infection)
		Faricimab	(11.8 Miscellaneous ophthalmic preparations)
		Fedratinib	(8.2 Malignant disease)
		Fenfluramine	(4.6 Seizures)
		Fentanyl	(15.1 General Anaesthesia)
		Ferric carboxymaltose (Ferinject)	(9.1 Blood and blood–forming organs)
		Ferric derisomaltose (previously known as Monofer)	(9.1 Blood and blood–forming organs)
		Fibryga (Human Fibrinogen)	(7.5 Obstetrics)
		Filgotinib	(1.1 Chronic bowel disorders)
		Filgotinib	(10.1 Arthritis)
		Fingolimod (oral)	(8.1 Immune system)
		Flammacerium cream	(13.2 Infections of the skin)
		Flecainide (intravenous)	(2.1 Arrhythmias)
		Fluconazole (parenteral)	(5.3 Fungal infection)
		Flucytosine (oral & parenteral)	(5.3 Fungal infection)
		Fludarabine (oral & parenteral)	(8.2 Malignant disease)
		Fluocinolone acetonide intravitreal injection 190micrograms (Iluvien)	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Fluorouracil (parenteral)	(8.2 Malignant disease)
		Follitropin beta	(6.7 Hypothalamic and anterior pituitary hormone related disorders)
		Fondaparinux	(2.3 Blood clots)
		Fosaprepitant	(4.4 Nausea and labyrinth disorders)
		Foscarnet sodium (parenteral)	(5.6 Viral infection)
		Foslevodopa–foscarbidopa	(4.3 Movement disorders)
		Fostamatinib	(9.1 Blood and blood–forming organs)
		Fremanezumab	(4.5 Pain)
		Gabapentin	(3.4 Cough and congestion)
		Galcanezumab	(4.5 Pain)
		Ganciclovir (parenteral)	(5.6 Viral infection)
		Gefitinib (oral)	(8.2 Malignant disease)
		Gemcitabine (parenteral)	(8.2 Malignant disease)
		Gemeprost pessary	(7.5 Obstetrics)
		Gemtuzumab ozogamicin (parenteral)	(8.2 Malignant disease)
		Gentamicin (intravesical)	(5.2 Bacterial infection)
		Gentamicin (nebulised)	(5.2 Bacterial infection)
		Gentamicin 0.1% cream	(13.2 Infections of the skin)
		Gentamicin 1.5% eye drops (unlicensed)	(11.3 Anti–infective eye preparations)
		Gilteritinib	(8.2 Malignant disease)
		Glatiramer acetate (parenteral)	(8.1 Immune system)
		Glecaprevir / Pibrentasvir (oral)	(5.6 Viral infection)
		Glofitamab	(8.2 Malignant disease)
		Glucarpidase	(8.2 Malignant disease)
		Glycerol phenylbutyrate (Ravicti)	(9.3 Metabolic disorders)
		Glycopyrronium	(15.1 General Anaesthesia)
		Golimumab	(1.1 Chronic bowel disorders)
		Golimumab	(10.1 Arthritis)
		Goserelin 3.6mg implant (Zoladex)	(6.6 Gonadotrophin responsive conditions)
		Granisetron	(4.4 Nausea and labyrinth disorders)
		Grazax	(3.2 Allergic conditions)
		Guselkumab (parenteral)	(13.3 Inflammatory skin conditions)
		Guselkumab	(10.1 Arthritis)
		Haem arginate infusion	(9.3 Metabolic disorders)
		Haloperidol (injection- non depot)	(4.2 Mental health disorders)
		Heparin Calcium	(2.3 Blood clots)
		Heparin Sodium	(2.3 Blood clots)
		Hepatitis B immunoglobulin	(14.1 Immunoglobulin therapy)
		Hepatitis B vaccine (HBvaxPRO 40microgram, Energix B)	(14.4 Vaccination)
		Hexamidine 0.1% eye drops (unlicensed)	(11.3 Anti–infective eye preparations)
		Hexaminolevulinate (Hexvix)	(17.1 Miscellaneous Preparations)
		Human normal immunoglobulin	(14.1 Immunoglobulin therapy)
		Humulin R U500	(6.3 Diabetes mellitus and hypoglycaemia)
		Hydralazine (intravenous)	(2.4 Blood pressure conditions)
		Hydrocortisone sodium phosphate 3.35mg/mL eye drops (Softacort)	(11.4 Corticosteroids and other anti–inflammatory preparations)
		Hydroquinone 5% / Hydrocortisone 1% / Tretinoin 0.1% cream (Pigmanorm)	(13.3 Inflammatory skin conditions)
		HyloDual preservative free eye drops	(11.8 Miscellaneous ophthalmic preparations)
		Ibandronic acid 2mg injection	(6.4 Disorders of bone metabolism)
		Ibandronic acid 3mg injection	(6.4 Disorders of bone metabolism)
		Ibrutinib (oral)	(8.2 Malignant disease)
		Icatibant (Firazyr)	(3.2 Allergic conditions)
		Idarubicin (oral)	(8.2 Malignant disease)
		Idarucizumab	(2.3 Blood clots)
		Idelalisib (oral)	(8.2 Malignant disease)
		Idursulfase	(9.3 Metabolic disorders)
		Ifosfamide (parenteral)	(8.2 Malignant disease)
		Iloprost	(2.4 Blood pressure conditions)
		Imatinib (oral)	(8.2 Malignant disease)
		Imiglucerase	(9.3 Metabolic disorders)
		Imlifidase	(8.1 Immune system)
		Independence Wound Protection/Collection Pouch Covers: VAP 1 (small), VAP 2 (regular), VAP 3 (large)	(17.1 Miscellaneous Preparations)
		Indinavir (oral)	(5.6 Viral infection)
		Infliximab (intravenous & subcutaneous)	(1.1 Chronic bowel disorders)
		Infliximab (intravenous & subcutaneous)	(13.3 Inflammatory skin conditions)
		Infliximab (intravenous & subcutaneous)	(4.3 Movement disorders)
		Infliximab	(10.1 Arthritis)
		Infliximab	(10.5 Soft tissue and joint disorders)
		Inotuzumab ozogamicin (parenteral)	(8.2 Malignant disease)
		Insulin eye drops	(11.8 Miscellaneous ophthalmic preparations)
		Interferon alfa (Roferon-A) (parenteral)	(5.6 Viral infection)
		Interferon alfa (Roferon-A) (parenteral)	(8.2 Malignant disease)
		Interferon alfa-2a 1 million units in 1mL eye drops (unlicensed)	(11.8 Miscellaneous ophthalmic preparations)
		Interferon alfa-2b 1 million units in 1mL eye drops (unlicensed)	(11.8 Miscellaneous ophthalmic preparations)
		Interferon beta (parenteral)	(8.1 Immune system)
		Interferon beta (parenteral)	(8.2 Malignant disease)
		Ipilimumab (parenteral)	(8.2 Malignant disease)
		Irinotecan hydrochloride (parenteral)	(8.2 Malignant disease)
		Iron dextran (CosmoFer)	(9.1 Blood and blood–forming organs)
		Iron sucrose (Venofer)	(9.1 Blood and blood–forming organs)
		Isatuximab (parenteral)	(8.2 Malignant disease)
		Isavuconazole (oral & parenteral)	(5.3 Fungal infection)
		Isoflurane	(15.1 General Anaesthesia)
		Isoniazid (oral)	(5.2 Bacterial infection)
		Isoprenaline	(2.7 Myocardial ischaemia)
		Isosorbide dinitrate Infusion	(2.7 Myocardial ischaemia)
		Isotretinoin capsules	(13.7 Rosacea and acne)
		Itulazax (Standardised allergen extract of pollen from white birch [Betula verrucosa])	(3.2 Allergic conditions)
		Ivacaftor / Tezacaftor	(3.3 Conditions affecting sputum viscosity)
		Ivacaftor	(3.3 Conditions affecting sputum viscosity)
		Ivermectin (oral) (unlicensed)	(5.4 Helminth infection)
		Ivermectin (oral)	(13.2 Infections of the skin)
		Ivosidenib	(8.2 Malignant disease)
		Ixazomib with Lenalidomide and Dexamethasone	(8.2 Malignant disease)
		Ixekizumab (parenteral)	(13.3 Inflammatory skin conditions)
		Ixekizumab	(10.1 Arthritis)
		Ketamine	(15.1 General Anaesthesia)
		Ketamine	(16.1 Pain due to cancer in adults- Palliative Care)
		Ketamine	(4.2 Mental health disorders)
		Ketamine	(4.5 Pain)
		Ketorolac injection	(15.1 General Anaesthesia)
		Ketorolac	(10.4 Pain and inflammation in musculoskeletal disorders)
		Labetalol (intravenous)	(2.4 Blood pressure conditions)
		Lamivudine (oral)	(5.6 Viral infection)
		Lanadelumab	(3.2 Allergic conditions)
		Lanreotide (parenteral)	(8.2 Malignant disease)
		Larotrectinib	(8.2 Malignant disease)
		LAT (Lidocaine, Adrenaline and Tetracaine) gel	(15.2 Local anaesthesia)
		Lebrikizumab	(13.3 Inflammatory skin conditions)
		Ledipasvir / Sofosbuvir	(5.6 Viral infection)
		Lenalidomide (oral)	(8.2 Malignant disease)
		Lenvatinib with Everolimus (oral)	(8.2 Malignant disease)
		Lenvatinib	(8.2 Malignant disease)
		Letermovir (oral)	(5.6 Viral infection)
		Levamisole (oral) (unlicensed)	(5.4 Helminth infection)
		Levetiracetam (parenteral)	(4.6 Seizures)
		Levobupivacaine 2.5mg/mL, 5mg/mL & 7.5mg/mL injection	(15.2 Local anaesthesia)
		Levofloxacin (nebulised)	(5.2 Bacterial infection)
		Levofloxacin (parenteral)	(5.2 Bacterial infection)
		Lidocaine 4% / Fluorescein 0.25% single-use eye drops	(11.7 Local anaesthetics)
		Lidocaine patch	(4.5 Pain)
		Lidocaine	(2.1 Arrhythmias)
		Linezolid (oral & parenteral)	(5.2 Bacterial infection)
		Liothyronine	(6.9 Thyroid disorders)
		Liposomal amphotericin (parenteral)	(5.3 Fungal infection)
		Liraglutide (Saxenda)	(1.8 Obesity)
		Lomitapide	(2.6 Hyperlipidaemia)
		Lomustine (oral)	(8.2 Malignant disease)
		Loncastuximab tesirine	(8.2 Malignant disease)
		Lopinavir / Ritonavir (oral) (Kaletra)	(5.6 Viral infection)
		Lorlatinib	(8.2 Malignant disease)
		Lumacaftor / Ivacaftor	(3.3 Conditions affecting sputum viscosity)
		Lumasiran	(9.3 Metabolic disorders)
		Lusutrombopag	(9.1 Blood and blood–forming organs)
		Lutetium (177Lu) oxodotreotide	(17.1 Miscellaneous Preparations)
		Lutetium (177Lu) vipivotide tetraxetan	(17.1 Miscellaneous Preparations)
		Macimorelin	(6.7 Hypothalamic and anterior pituitary hormone related disorders)
		Magnesium sulfate (unlicensed indications)	(7.5 Obstetrics)
		Magnesium sulphate 50% (parenteral)	(9.2 Fluid and electrolyte imbalances)
		Magnesium sulphate	(2.1 Arrhythmias)
		MagTab	(9.2 Fluid and electrolyte imbalances)
		Mannitol dry powder for inhalation	(3.3 Conditions affecting sputum viscosity)
		Mannitol Infusion 20%	(2.8 Oedema)
		Maraviroc (oral)	(5.6 Viral infection)
		Maribavir	(5.6 Viral infection)
		Mavacamten	(2.5 Heart Failure)
		Mefloquine (oral)	(5.5 Protozoal infection)
		Melatonin modified-release	(4.7 Sleep disorders)
		Melatonin	(4.7 Sleep disorders)
		Melphalan (oral & parenteral)	(8.2 Malignant disease)
		Meningococcal Group B vaccine (Bexsero)	(14.4 Vaccination)
		Mepolizumab	(3.1 Airways disease, obstructive)
		Mercaptamine	(11.8 Miscellaneous ophthalmic preparations)
		Mercaptamine	(9.3 Metabolic disorders)
		Mercaptopurine (oral)	(8.2 Malignant disease)
		Meropenem (parenteral)	(5.2 Bacterial infection)
		Metaraminol	(2.4 Blood pressure conditions)
		Methacholine (Provocholine) powder for nebuliser solution	(3.6 Respiratory depression, respiratory distress syndrome and apnoea)
		Methohexitone	(15.1 General Anaesthesia)
		Methotrexate (parenteral)	(8.2 Malignant disease)
		Methoxsalen (Uvadex)	(17.1 Miscellaneous Preparations)
		Methoxy polyethylene glycol-epoetin beta (Mircera)	(9.1 Blood and blood–forming organs)
		Methoxyflurane (inhaled) (Penthrox)	(15.1 General Anaesthesia)
		Methoxyflurane (inhaled) (Penthrox)	(15.1 General Anaesthesia)
		Methoxyflurane (inhaled) (Penthrox)	(15.1 General Anaesthesia)
		Methyl aminolevulinate (Metvix)	(13.5 Photodamage)
		Methylphenidate	(4.7 Sleep disorders)
		Methysergide	(4.5 Pain)
		Metoprolol (intravenous)	(2.4 Blood pressure conditions)
		Metronidazole (parenteral)	(5.2 Bacterial infection)
		Mexiletine (NaMuscla)	(4.3 Movement disorders)
		Mexiletine	(2.1 Arrhythmias)
		Micafungin (parenteral)	(5.3 Fungal infection)
		Midazolam (parenteral)	(4.6 Seizures)
		Midazolam 40mg/mL / Lignocaine 20mg/mL nasal solution	(15.1 General Anaesthesia)
		Midodrine	(2.4 Blood pressure conditions)
		Midostaurin (oral)	(8.2 Malignant disease)
		Mifamurtide (parenteral)	(8.2 Malignant disease)
		Mifepristone (oral)	(7.3 Contraception)
		Mifepristone	(7.5 Obstetrics)
		Milrinone	(2.5 Heart Failure)
		Mirikizumab	(1.1 Chronic bowel disorders)
		Misoprostol (oral)	(7.5 Obstetrics)
		Misoprostol	(7.3 Contraception)
		Mitomycin (parenteral & bladder instillation)	(8.2 Malignant disease)
		Mitomycin 0.02% and 0.04% eye drops (unlicensed)	(11.8 Miscellaneous ophthalmic preparations)
		Mitotane (oral)	(8.2 Malignant disease)
		Mitoxantrone (parenteral)	(8.2 Malignant disease)
		Mivacurium	(15.1 General Anaesthesia)
		Mobocertinib (oral)	(8.2 Malignant disease)
		Mogamulizumab	(8.2 Malignant disease)
		Molnupiravir (Lagevrio)	(5.7 Treatment of COVID-19)
		Momelotinib	(8.2 Malignant disease)
		Morphine	(15.1 General Anaesthesia)
		Moxifloxacin 0.5% eye drops (Moxivig)	(11.3 Anti–infective eye preparations)
		Mycophenolate mofetil (oral & parenteral)	(8.1 Immune system)
		Mycophenolic acid (as mycophenolate sodium) (oral)	(8.1 Immune system)
		N-acetylcisteine (NAC) mixed with simeticone	(17.1 Miscellaneous Preparations)
		Nalmefene	(4.8 Substance dependence)
		Natalizumab (parenteral)	(8.1 Immune system)
		Nelarabine (parenteral)	(8.2 Malignant disease)
		Nelfinavir (oral)	(5.6 Viral infection)
		Neostigmine / Glycopyrronium	(15.1 General Anaesthesia)
		Neostigmine	(15.1 General Anaesthesia)
		Neratinib (oral)	(8.2 Malignant disease)
		Netupitant 300mg / Palonosetron 0.5mg (Akynzeo)	(4.4 Nausea and labyrinth disorders)
		Nevirapine (oral)	(5.6 Viral infection)
		Nicardipine (intravenous)	(2.4 Blood pressure conditions)
		Nifedipine (unlicensed)	(7.5 Obstetrics)
		Nilotinib (oral)	(8.2 Malignant disease)
		Nimodipine	(2.4 Blood pressure conditions)
		Nimodipine	(2.2 Bleeding disorders)
		Nintedanib (oral)	(8.2 Malignant disease)
		Nintedanib	(3.5 Interstitial Lung Disease)
		Niraparib (oral)	(8.2 Malignant disease)
		Nirmatrelvir and Ritonavir (Paxlovid)	(5.7 Treatment of COVID-19)
		Nitrous oxide	(15.1 General Anaesthesia)
		Nivolumab (parenteral)	(8.2 Malignant disease)
		Normal human immunoglobulins	(14.1 Immunoglobulin therapy)
		Nusinersen	(10.3 Neuromuscular disorders)
		Nutritain	(9.6 Vitamin deficiencies)
		Nutryelt	(9.4 Trace element deficiencies)
		Obeticholic Acid	(1.7 Liver disorders and related conditions)
		Obinutuzumab (parenteral)	(8.2 Malignant disease)
		Ocrelizumab (parenteral)	(8.1 Immune system)
		Octreotide (parenteral)	(8.2 Malignant disease)
		Octreotide	(16.2 Gastrointestinal symptoms- Palliative Care)
		Ofatumumab (parenteral)	(8.1 Immune system)
		Ofloxacin (parenteral)	(5.2 Bacterial infection)
		Olaparib	(8.2 Malignant disease)
		Omalizumab	(13.3 Inflammatory skin conditions)
		Omalizumab	(3.1 Airways disease, obstructive)
		Ombitasvir / Paritaprevir / Ritonavir (oral) (Viekirax)	(5.6 Viral infection)
		Ombitasvir / Paritaprevir / Ritonavir with Dasabuvir (oral) (Exviera)	(5.6 Viral infection)
		Onasemnogene abeparvovec	(10.3 Neuromuscular disorders)
		OralVac	(3.2 Allergic conditions)
		Oritavancin (parenteral)	(5.2 Bacterial infection)
		Osimertinib (oral)	(8.2 Malignant disease)
		Oxaliplatin (parenteral)	(8.2 Malignant disease)
		Oxybuprocaine 0.4% single-use eye drops	(11.7 Local anaesthetics)
		Oxycodone (PCA)	(4.5 Pain)
		Oxytocin (parenteral)	(7.5 Obstetrics)
		Oxytocin / Ergometrine (Syntometrine)	(7.5 Obstetrics)
		Oxytocin	(7.5 Obstetrics)
		Ozanimod	(1.1 Chronic bowel disorders)
		Paclitaxel (parenteral)	(8.2 Malignant disease)
		Palbociclib (oral)	(8.2 Malignant disease)
		Paliperidone palmitate injection (Xeplion)	(4.2 Mental health disorders)
		Palivizumab	(5.6 Viral infection)
		Palonosetron	(4.4 Nausea and labyrinth disorders)
		Pancuronium	(15.1 General Anaesthesia)
		Panitumumab (parenteral)	(8.2 Malignant disease)
		Panobinostat (oral)	(8.2 Malignant disease)
		Paraldehyde	(4.6 Seizures)
		Parecoxib	(15.1 General Anaesthesia)
		Pasireotide (subcutaneous)	(8.2 Malignant disease)
		Pasireotide	(6.2 Corticosteroid responsive conditions)
		Patiromer	(9.2 Fluid and electrolyte imbalances)
		Pazopanib (oral)	(8.2 Malignant disease)
		Pegaspargase	(8.2 Malignant disease)
		Pegcetacoplan	(9.1 Blood and blood–forming organs)
		Peginterferon alfa (parenteral)	(5.6 Viral infection)
		Peginterferon alfa (parenteral)	(8.2 Malignant disease)
		Peginterferon beta-1a	(8.2 Malignant disease)
		Pegunigalsidase alfa	(9.3 Metabolic disorders)
		Pegvisomant	(6.7 Hypothalamic and anterior pituitary hormone related disorders)
		Pembrolizumab (parenteral)	(8.2 Malignant disease)
		Pemetrexed (parenteral)	(8.2 Malignant disease)
		Pemigatinib (oral)	(8.2 Malignant disease)
		Pentamidine (nebulised)	(5.3 Fungal infection)
		Pentamidine (parenteral)	(5.3 Fungal infection)
		Pentosan polysulfate sodium	(7.1 Bladder and urinary disorders)
		Pentostatin (parenteral)	(8.2 Malignant disease)
		Peppermint oil enema	(1.2 Constipation and bowel cleansing)
		Perflutren (Luminity)	(17.1 Miscellaneous Preparations)
		Pertuzumab (parenteral)	(8.2 Malignant disease)
		Phenobarbital (parenteral)	(4.6 Seizures)
		Phenoxybenzamine	(2.4 Blood pressure conditions)
		Phentolamine	(2.4 Blood pressure conditions)
		Phenylephrine 2.5% eye drops (unlicensed)	(11.5 Mydriatics and cycloplegics)
		Phenylephrine	(2.4 Blood pressure conditions)
		PHMB (Polyhexamethylene biguanide hydrochloride) 0.02% and 0.06% eye drops (unlicensed)	(11.3 Anti–infective eye preparations)
		Piperacillin / Tazobactam (parenteral)	(5.2 Bacterial infection)
		Pirfenidone	(3.5 Interstitial Lung Disease)
		Pixantrone (parenteral)	(8.2 Malignant disease)
		Plasma-Lyte 148	(9.5 Nutrition)
		Polatuzumab vedotin (parenteral)	(8.2 Malignant disease)
		Pollinex	(3.2 Allergic conditions)
		Pomalidomide (oral)	(8.2 Malignant disease)
		Ponatinib (oral)	(8.2 Malignant disease)
		Ponesimod (oral)	(8.1 Immune system)
		Posaconazole (oral)	(5.3 Fungal infection)
		Potassium acid phosphate sterile solution for injection {13.6%}	(9.2 Fluid and electrolyte imbalances)
		Potassium ascorbate 10% eye drops (unlicensed)	(11.8 Miscellaneous ophthalmic preparations)
		Potassium Chloride 600mg (8mmol) modified release tablets	(9.2 Fluid and electrolyte imbalances)
		Potassium chloride prefilled syringe (50mmol/50mL {7.5%})	(9.2 Fluid and electrolyte imbalances)
		Prasterone (DHEA) gel	(7.6 Vaginal and vulval conditions)
		Praziquantel (oral) (unlicensed)	(5.4 Helminth infection)
		Praziquantel (oral) (unlicensed)	(5.4 Helminth infection)
		Primaquine (oral) (unlicensed)	(5.3 Fungal infection)
		Primaquine (oral) (unlicensed)	(5.5 Protozoal infection)
		Pristinamycin (oral) (unlicensed)	(5.2 Bacterial infection)
		Probenecid	(5.2 Bacterial infection)
		Procaine benzylpenicillin (parenteral) (unlicensed)	(5.2 Bacterial infection)
		Procarbazine (oral)	(8.2 Malignant disease)
		Progesterone pessaries (Cyclogest)	(7.5 Obstetrics)
		Proguanil hydrochloride (oral)	(5.5 Protozoal infection)
		Proguanil hydrochloride / Atovaquone (oral) (Malarone)	(5.5 Protozoal infection)
		Prontoderm Foam	(13.9 Skin cleansers, antiseptics and desloughing agents)
		Propafenone (intravenous)	(2.1 Arrhythmias)
		Propofol 1% (10mg/mL)	(15.1 General Anaesthesia)
		Propofol 2% (20mg/mL)	(15.1 General Anaesthesia)
		Propofol	(4.6 Seizures)
		Protamine	(2.3 Blood clots)
		Prothionamide (oral) (unlicensed)	(5.2 Bacterial infection)
		Proxymetacaine 0.5% single-use eye drops	(11.7 Local anaesthetics)
		Pyrazinamide (oral) (unlicensed)	(5.2 Bacterial infection)
		Pyrimethamine (oral)	(5.5 Protozoal infection)
		Pyrimethamine / Sulfadoxine (oral) (unlicensed) (Fansidar)	(5.5 Protozoal infection)
		Quinagolide	(6.5 Dopamine responsive conditions)
		Quixil	(2.2 Bleeding disorders)
		Quizartinib	(8.2 Malignant disease)
		Rabies immunoglobulin	(14.1 Immunoglobulin therapy)
		Raltegravir (oral)	(5.6 Viral infection)
		Ranibizumab	(11.8 Miscellaneous ophthalmic preparations)
		Rasburicase (parenteral)	(8.2 Malignant disease)
		Ravulizumab	(8.2 Malignant disease)
		Ravulizumab	(9.1 Blood and blood–forming organs)
		Regadenoson (Rapiscan)	(17.1 Miscellaneous Preparations)
		Regorafenib (oral)	(8.2 Malignant disease)
		Remdesivir	(5.7 Treatment of COVID-19)
		Remifentanil	(15.1 General Anaesthesia)
		Reslizumab	(3.1 Airways disease, obstructive)
		Rezafungin (parenteral)	(5.3 Fungal infection)
		Ribavirin (oral)	(5.6 Viral infection)
		Ribociclib (oral)	(8.2 Malignant disease)
		Rifabutin (oral)	(5.2 Bacterial infection)
		Rifampicin (oral)	(5.2 Bacterial infection)
		Rifampicin (parenteral)	(5.2 Bacterial infection)
		Rifampicin / Isoniazid (oral) (Rifinah)	(5.2 Bacterial infection)
		Rifampicin / Isoniazid / Pyrazinamide (oral) (Rifater)	(5.2 Bacterial infection)
		Rifampicin / Isoniazid / Pyrazinamide / Ethambutol (oral) (Voractiv)	(5.2 Bacterial infection)
		Rifaximin (oral)	(5.2 Bacterial infection)
		Rilpivirine (oral)	(5.6 Viral infection)
		Rilpivirine / Emtricitabine / Tenofovir (oral) (Eviplera)	(5.6 Viral infection)
		Rilpivirine / Emtricitabine / Tenofovir Alafenamide (oral) (Odefsey)	(5.6 Viral infection)
		Riociguat	(2.4 Blood pressure conditions)
		Risankizumab	(1.1 Chronic bowel disorders)
		Risankizumab	(10.1 Arthritis)
		Risankizumab	(13.3 Inflammatory skin conditions)
		Risdiplam	(10.3 Neuromuscular disorders)
		Risperidone injection (Consta)	(4.2 Mental health disorders)
		Ritlecitinib	(13.8 Scalp and hair conditions)
		Ritonavir (oral)	(5.6 Viral infection)
		Rituximab (parenteral)	(8.2 Malignant disease)
		Rituximab biosimilar (parenteral)	(8.2 Malignant disease)
		Rituximab	(10.1 Arthritis)
		Rivaroxaban	(2.3 Blood clots)
		Rocuronium	(15.1 General Anaesthesia)
		Romiplostim	(9.1 Blood and blood–forming organs)
		Romosozumab	(6.4 Disorders of bone metabolism)
		Ropivacaine	(15.2 Local anaesthesia)
		Roxadustat	(9.1 Blood and blood–forming organs)
		Rucaparib	(8.2 Malignant disease)
		Ruxolitinib (oral)	(8.2 Malignant disease)
		Sacituzumab govitecan	(8.2 Malignant disease)
		Sapropterin dihydrochloride	(9.5 Nutrition)
		Saquinavir (oral)	(5.6 Viral infection)
		Sarilumab	(10.1 Arthritis)
		Secukinumab (parenteral)	(13.3 Inflammatory skin conditions)
		Secukinumab	(10.1 Arthritis)
		Selective Internal Radiation Therapies	(8.2 Malignant disease)
		Selenase oral solution	(9.4 Trace element deficiencies)
		Selinexor	(8.2 Malignant disease)
		Selpercatinib	(8.2 Malignant disease)
		Semaglutide (Wegovy)	(1.8 Obesity)
		Sevelamer carbonate sachets	(9.2 Fluid and electrolyte imbalances)
		Sevoflurane	(15.1 General Anaesthesia)
		Sildenafil (oral & parenteral)	(2.4 Blood pressure conditions)
		Siltuximab	(8.1 Immune system)
		Siponimod (oral)	(8.1 Immune system)
		Sirolimus (oral)	(8.1 Immune system)
		Sodium aurothiomalate	(10.1 Arthritis)
		Sodium chloride 5%	(9.2 Fluid and electrolyte imbalances)
		Sodium clodronate (Clasteon® or Loron)	(6.4 Disorders of bone metabolism)
		Sodium nitroprusside	(2.4 Blood pressure conditions)
		Sodium oxybate	(4.7 Sleep disorders)
		Sodium tetradecyl sulphate	(2.9 Vascular disease)
		Sodium thiopentone	(4.6 Seizures)
		Sodium valproate (parenteral)	(4.6 Seizures)
		Sodium valproate injection	(4.6 Seizures)
		Sodium zirconium cyclosilicate	(9.2 Fluid and electrolyte imbalances)
		Sofosbuvir (oral)	(5.6 Viral infection)
		Sofosbuvir / Velpatasvir / Voxilaprevir	(5.6 Viral infection)
		Sofosbuvir / Velpatasvir	(5.6 Viral infection)
		Solriamfetol	(4.7 Sleep disorders)
		Somatropin (synthetic Human Growth Hormone)	(6.7 Hypothalamic and anterior pituitary hormone related disorders)
		Sorafenib (oral)	(8.2 Malignant disease)
		Sotalol (intravenous)	(2.1 Arrhythmias)
		Sotorasib (oral)	(8.2 Malignant disease)
		Sotrovimab (Xevudy)	(5.7 Treatment of COVID-19)
		Stavudine (oral)	(5.6 Viral infection)
		Sterile potassium chloride concentrate (20mmol/10mL {15%})	(9.2 Fluid and electrolyte imbalances)
		Streptokinase	(2.7 Myocardial ischaemia)
		Streptomycin (parenteral) (unlicensed)	(5.2 Bacterial infection)
		Succinylated gelatin 40g (4%) (Gelofusine, Isoplex)	(9.2 Fluid and electrolyte imbalances)
		Sucralfate 3g/20mL enema	(1.4 Disorders of gastric acid and ulceration)
		Sucralfate liquid (oral)	(12.3 Oropharynx)
		Sugammadex	(15.1 General Anaesthesia)
		Sulfur hexafluoride lipid microspheres (SonoVue)	(17.1 Miscellaneous Preparations)
		Sunitinib (oral)	(8.2 Malignant disease)
		Suxamethonium	(15.1 General Anaesthesia)
		Tacrolimus (oral & parenteral)	(8.1 Immune system)
		Tacrolimus 0.03%, 0.1% ointment (unlicensed)	(11.8 Miscellaneous ophthalmic preparations)
		Tadalafil (oral)	(2.4 Blood pressure conditions)
		Tafamidis	(2.5 Heart Failure)
		Talazoparib	(8.2 Malignant disease)
		Talimogene (parenteral)	(8.2 Malignant disease)
		Talimogene laherparepvec (parenteral)	(8.2 Malignant disease)
		Tapentadol immediate-release	(4.5 Pain)
		Teclistamab	(8.2 Malignant disease)
		Tecovirimat	(5.6 Viral infection)
		Teduglutide	(1.1 Chronic bowel disorders)
		Tegafur / Uracil (oral)	(8.2 Malignant disease)
		Teicoplanin (parenteral)	(5.2 Bacterial infection)
		Telbivudine (oral)	(5.6 Viral infection)
		Temocillin (parenteral)	(5.2 Bacterial infection)
		Temozolomide (oral)	(8.2 Malignant disease)
		Temsirolimus (parenteral)	(8.2 Malignant disease)
		Tenecteplase	(2.3 Blood clots)
		Tenecteplase	(2.7 Myocardial ischaemia)
		Tenofovir (oral)	(5.6 Viral infection)
		Tenofovir / Efavirenz / Emtricitabine (oral) (Atripla)	(5.6 Viral infection)
		Tenofovir / Efavirenz / Emtricitabine / Cobicistat (oral) (Stribild)	(5.6 Viral infection)
		Tenofovir disoproxil (oral)	(5.6 Viral infection)
		Tepotinib	(8.2 Malignant disease)
		Terbutaline	(7.5 Obstetrics)
		Teriflunomide (oral)	(8.1 Immune system)
		Teriparatide	(6.4 Disorders of bone metabolism)
		Terizidone (oral) (unlicensed)	(5.2 Bacterial infection)
		Terlipressin	(1.7 Liver disorders and related conditions)
		Testosterone implant	(6.8 Sex hormone responsive conditions)
		Tetanus immunoglobulin	(14.1 Immunoglobulin therapy)
		Tetracosactide 250micrograms & 1mg depot	(6.7 Hypothalamic and anterior pituitary hormone related disorders)
		Tezepelumab	(3.1 Airways disease, obstructive)
		Thalidomide (oral) (Celgene)	(8.2 Malignant disease)
		Thalidomide	(3.4 Cough and congestion)
		Thealoz Duo preservative free eye drops	(11.8 Miscellaneous ophthalmic preparations)
		Thiamine (parenteral) as Pabrinex	(4.6 Seizures)
		Thiopental sodium	(15.1 General Anaesthesia)
		Thiotepa (parenteral)	(8.2 Malignant disease)
		Tigecycline (parenteral)	(5.2 Bacterial infection)
		Tigecycline (parenteral)	(5.2 Bacterial infection)
		Tildrakizumab (parenteral)	(13.3 Inflammatory skin conditions)
		Tioguanine (Thioguanine) (oral)	(8.2 Malignant disease)
		Tiopronin	(9.3 Metabolic disorders)
		Tirofiban	(2.3 Blood clots)
		Tirofiban	(2.7 Myocardial ischaemia)
		Tisagenlecleucel	(8.2 Malignant disease)
		Tisseel	(2.2 Bleeding disorders)
		Tivozanib (oral)	(8.2 Malignant disease)
		Tobramycin (inhaled)	(3.1 Airways disease, obstructive)
		Tobramycin (inhaled)	(5.2 Bacterial infection)
		Tobramycin (nebulised)	(3.1 Airways disease, obstructive)
		Tobramycin (nebulised)	(5.2 Bacterial infection)
		Tobramycin (parenteral)	(3.1 Airways disease, obstructive)
		Tobramycin (parenteral)	(5.2 Bacterial infection)
		Tocilizumab	(10.1 Arthritis)
		Tocilizumab	(5.7 Treatment of COVID-19)
		Tofacitinib	(1.1 Chronic bowel disorders)
		Tofacitinib	(10.1 Arthritis)
		Tolcapone	(4.3 Movement disorders)
		Tolvaptan	(6.1 Antidiuretic hormone disorders)
		Topotecan (oral)	(8.2 Malignant disease)
		Trabectedin (parenteral)	(8.2 Malignant disease)
		Tralokinumab	(13.3 Inflammatory skin conditions)
		Trametinib (oral)	(8.2 Malignant disease)
		Trastuzumab (parenteral)	(8.2 Malignant disease)
		Treosulfan (parenteral)	(8.2 Malignant disease)
		Tretinoin (oral)	(8.2 Malignant disease)
		Triamcinolone acetonide 0.1% / Gramicidin 0.025% / Neomycin sulphate 0.25% / Nystatin 100,000 units/g ointment (Otocomb Otic Ear)	(12.1 Ear)
		Trientine	(9.3 Metabolic disorders)
		Trifluridine-tipiracil (oral)	(8.2 Malignant disease)
		Triptorelin 3mg injection (Decapeptyl SR)	(6.6 Gonadotrophin responsive conditions)
		Tucatinib (oral)	(8.2 Malignant disease)
		Ubidecarenone (Co-enzyme Q10)	(9.3 Metabolic disorders)
		Udderly Smooth cream	(13.1 Dry and scaling skin disorders)
		Ulipristal acetate (Esmya)	(7.3 Contraception)
		Upadacitinib	(1.1 Chronic bowel disorders)
		Upadacitinib	(10.1 Arthritis)
		Upadacitinib	(13.3 Inflammatory skin conditions)
		Urocit K	(7.1 Bladder and urinary disorders)
		Urokinase	(2.3 Blood clots)
		Uromune Sublingual Spray Vaccine	(5.2 Bacterial infection)
		Ustekinumab (parenteral)	(13.3 Inflammatory skin conditions)
		Ustekinumab	(1.1 Chronic bowel disorders)
		Ustekinumab	(10.1 Arthritis)
		Vaginal micronised progesterone (Cyclogest pessaries)	(7.5 Obstetrics)
		Valganciclovir (oral)	(5.6 Viral infection)
		Valganciclovir solution (oral)	(5.6 Viral infection)
		Vancomycin (parenteral)	(5.2 Bacterial infection)
		Vancomycin 1.4% eye drops (unlicensed)	(11.3 Anti–infective eye preparations)
		Vancomycin 5% eye drops (unlicensed)	(11.3 Anti–infective eye preparations)
		Vancomycin 50mg/mL (unlicensed)	(11.3 Anti–infective eye preparations)
		Vandetanib (oral)	(8.2 Malignant disease)
		Varicella-Zoster immunoglobulin	(14.1 Immunoglobulin therapy)
		Varicella-Zoster vaccine (Varilrix)	(14.4 Vaccination)
		Vecuronium	(15.1 General Anaesthesia)
		Vedolizumab (intravenous & subcutaneous)	(1.1 Chronic bowel disorders)
		Vemurafenib (oral)	(8.2 Malignant disease)
		Venetoclax (oral)	(8.2 Malignant disease)
		Verapamil (immediate release tablets)	(4.5 Pain)
		Verapamil (intravenous)	(2.1 Arrhythmias)
		Verapamil	(2.2 Bleeding disorders)
		Veraseal	(17.1 Miscellaneous Preparations)
		Vericiguat	(2.5 Heart Failure)
		Verteporfin	(11.8 Miscellaneous ophthalmic preparations)
		Vigabatrin	(4.6 Seizures)
		Vinblastine (parenteral)	(8.2 Malignant disease)
		Vincristine (parenteral)	(8.2 Malignant disease)
		Vinorelbine (parenteral)	(8.2 Malignant disease)
		Vismodegib (oral)	(8.2 Malignant disease)
		Vitamins B & C high potency (intravenous) (Pabrinex)	(9.6 Vitamin deficiencies)
		Vitlipid N adult	(9.6 Vitamin deficiencies)
		Voclosporin	(10.1 Arthritis)
		Volanesorsen	(2.6 Hyperlipidaemia)
		Voriconazole (oral & parenteral)	(5.3 Fungal infection)
		Voriconazole 1% eye drops (unlicensed)	(11.3 Anti–infective eye preparations)
		Voxelotor	(9.1 Blood and blood–forming organs)
		Vutrisiran	(4.5 Pain)
		Zanamivir (intravenous)	(5.6 Viral infection)
		Zanubrutinib (oral)	(8.2 Malignant disease)
		Zidovudine (oral & parenteral)	(5.6 Viral infection)
		Zoledronic acid	(6.4 Disorders of bone metabolism)